https://www.novartis.com/us-en/ 2026-07-21T14:30:28-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/victor-bulto 2025-10-22T11:50:24-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/sonia-choi 2025-10-22T11:50:12-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/des-creary 2026-03-06T17:01:15-05:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/gail-horwood 2025-10-22T11:49:33-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/reshema-kemps-polanco 2026-05-08T15:32:33-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/shefali-kothari 2025-10-22T11:49:09-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/katie-mazuk 2026-05-18T13:21:42-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/melissa-mckerracher 2025-10-22T11:48:31-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/liviu-niculescu 2025-11-19T14:27:37-05:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/courtney-piron 2026-01-02T09:41:19-05:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/rob-rubinsky 2026-05-18T13:21:12-04:00 daily 1.0 https://www.novartis.com/us-en/robert-stanley 2026-05-08T14:47:44-04:00 daily 1.0 https://www.novartis.com/us-en/chanel-leitch 2026-06-02T11:47:00-04:00 daily 1.0 https://www.novartis.com/us-en/events/end-zone-zen-new-york-giants 2026-09-02T11:05:24-04:00 daily 1.0 https://www.novartis.com/us-en/events/team-health-dallas-cowboys 2026-09-03T11:52:50-04:00 daily 1.0 https://www.novartis.com/us-en/events/my-cause-my-cleats-los-angeles-rams 2026-09-02T11:04:22-04:00 daily 1.0 https://www.novartis.com/us-en/events/team-against-prostate-cancer-baltimore-ravens 2026-09-02T11:03:49-04:00 daily 1.0 https://www.novartis.com/us-en/page-not-found 2022-03-30T01:06:54-04:00 daily 1.0 https://www.novartis.com/us-en/news/news-archive 2024-03-26T10:29:49-04:00 daily 1.0 https://www.novartis.com/us-en/careers 2026-03-05T14:26:50-05:00 daily 1.0 https://www.novartis.com/us-en/patients-and-caregivers/novartis-commitment-patients-and-caregivers 2025-04-25T14:06:51-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethical-behavior 2024-03-26T09:33:56-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethical-behavior/code-ethics 2025-10-06T10:48:38-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethical-behavior/speakup 2025-12-17T17:25:45-05:00 daily 1.0 https://www.novartis.com/us-en/terms-use 2024-03-27T09:34:26-04:00 daily 1.0 https://www.novartis.com/us-en/careers/awards-recognition 2025-02-08T23:18:05-05:00 daily 1.0 https://www.novartis.com/us-en/careers/employee-benefits 2025-04-25T13:56:35-04:00 daily 1.0 https://www.novartis.com/us-en/patients-and-caregivers/patient-assistance/novartis-patient-support 2025-11-11T11:56:34-05:00 daily 1.0 https://www.novartis.com/us-en/esg/corporate-responsibility/people-and-communities 2024-03-26T10:15:18-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethical-behavior/business-principles 2024-03-26T09:42:26-04:00 daily 1.0 https://www.novartis.com/us-en/esg/environmental-sustainability 2025-01-29T11:43:09-05:00 daily 1.0 https://www.novartis.com/us-en/esg/ethics-risk-and-compliance/compliance-program 2025-07-02T09:57:58-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethics-risk-and-compliance/state-laws 2026-06-17T11:40:38-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethical-behavior/phrma-code-interactions-healthcare-professionals 2024-03-26T09:39:51-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethics-risk-and-compliance/payments-hcps-hcos 2022-03-28T12:02:01-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethics-risk-and-compliance/state-laws/ca-health-and-safety-code-ss119402 2026-06-17T11:39:17-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethics-risk-and-compliance/state-laws/annual-description-comprehensive-compliance-program 2026-06-17T11:38:41-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethics-risk-and-compliance/state-laws/california-npc-declaration-compliance 2026-06-17T11:40:13-04:00 daily 1.0 https://www.novartis.com/us-en/news/us-media-contacts 2025-01-08T13:48:58-05:00 daily 1.0 https://www.novartis.com/us-en/contact-select 2025-10-17T12:16:10-04:00 daily 1.0 https://www.novartis.com/us-en/careers/nibr-careers-frequently-asked-questions 2022-03-13T11:21:01-04:00 daily 1.0 https://www.novartis.com/us-en/recall-zofran-and-entresto-packages 2025-01-30T03:47:16-05:00 daily 1.0 https://www.novartis.com/us-en/esg/ethics-risk-and-compliance/drug-supply-chain-security-act-information 2025-01-30T03:49:14-05:00 daily 1.0 https://www.novartis.com/us-en/esg/corporate-responsibility/novartis-society-integrated-report 2025-02-10T10:01:00-05:00 daily 1.0 https://www.novartis.com/us-en/about/novartis-us/company-glance/value-and-pricing 2022-03-28T12:51:24-04:00 daily 1.0 https://www.novartis.com/us-en/esg/corporate-responsibility/novartis-us-foundation 2022-03-28T13:05:34-04:00 daily 1.0 https://www.novartis.com/us-en/about/novartis-us/our-commitment-patients-caregivers 2022-03-25T09:37:33-04:00 daily 1.0 https://www.novartis.com/us-en/patients-and-caregivers/patient-assistance 2025-04-25T14:04:43-04:00 daily 1.0 https://www.novartis.com/us-en/healthcare-professionals/external-funding-healthcare-professionals 2026-08-06T10:01:08-04:00 daily 1.0 https://www.novartis.com/us-en/healthcare-professionals/external-funding/educational-grants 2026-08-06T10:00:29-04:00 daily 1.0 https://www.novartis.com/us-en/healthcare-professionals/external-funding/sponsorships-and-memberships 2026-08-06T09:59:54-04:00 daily 1.0 https://www.novartis.com/us-en/healthcare-professionals/external-funding/faqs 2026-08-06T09:59:11-04:00 daily 1.0 https://www.novartis.com/us-en/healthcare-professionals/external-funding/educational-grants/professional-medical-education-grants 2026-08-26T11:30:19-04:00 daily 1.0 https://www.novartis.com/us-en/healthcare-professionals/external-funding/educational-grants/patient-education-grants 2026-08-06T10:02:22-04:00 daily 1.0 https://www.novartis.com/us-en/about/inclusion-and-belonging/supplier-innovation-development 2026-02-04T13:07:58-05:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-research 2024-10-29T03:05:19-04:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-digital 2025-01-24T09:37:59-05:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-information-technology-it 2025-01-24T09:40:08-05:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-procurement 2024-10-29T03:06:16-04:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-health-safety-environment 2024-10-29T03:07:09-04:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-medical-development 2025-01-24T09:38:36-05:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-people-organization 2025-01-24T09:38:47-05:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-communications-and-advocacy 2022-03-29T03:38:49-04:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-consulting 2025-01-24T09:39:32-05:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-technical-operations 2023-11-13T07:49:07-05:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-strategy 2022-03-29T03:13:12-04:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-commercial 2024-10-29T03:08:16-04:00 daily 1.0 https://www.novartis.com/us-en/news/step-program/age-related-macular-degeneration-amd 2022-03-28T10:07:02-04:00 daily 1.0 https://www.novartis.com/us-en/careers/early-talent 2026-07-30T11:13:13-04:00 daily 1.0 https://www.novartis.com/us-en/about/contact-us 2025-10-17T12:17:31-04:00 daily 1.0 https://www.novartis.com/us-en/esg/corporate-responsibility/beacon-hope/beacon-hope-solutions-improving-access-healthcare 2025-06-13T11:51:01-04:00 daily 1.0 https://www.novartis.com/us-en/gilenya-guides-community-privacy-policy 2022-07-22T15:01:14-04:00 daily 1.0 https://www.novartis.com/us-en/privacy 2026-05-28T13:12:49-04:00 daily 1.0 https://www.novartis.com/us-en/about/external-funding/educational-grants/professional-medical-education-grants/request-proposal-rfp-paroxysmal-nocturnal-hemoglobinuria-pnh 2023-01-20T12:59:44-05:00 daily 1.0 https://www.novartis.com/us-en/about/external-funding/educational-grants/professional-medical-education-grants/request-proposal-rfp-hyperlipidemia 2023-01-20T12:58:36-05:00 daily 1.0 https://www.novartis.com/us-en/news/radioligand-therapy-supply-information/patient-faqs 2023-06-02T12:52:01-04:00 daily 1.0 https://www.novartis.com/us-en/esg/beacon-hope/paving-way-brighter-more-equitable-future 2024-03-26T10:24:51-04:00 daily 1.0 https://www.novartis.com/us-en/patients-and-caregivers/diseases/chronic-hives-chronic-urticaria 2026-07-08T13:58:16-04:00 daily 1.0 https://www.novartis.com/us-en/patients-and-caregivers/diseases/hidradenitis-suppurativa 2026-08-21T13:51:53-04:00 daily 1.0 https://www.novartis.com/us-en/privacy/consumer-health 2025-10-23T03:52:29-04:00 daily 1.0 https://www.novartis.com/us-en/patients-and-caregivers/diseases/prostate-cancer 2026-03-13T13:04:32-04:00 daily 1.0 https://www.novartis.com/us-en/patients-and-caregivers/diseases/paroxysmal-nocturnal-hemoglobinuria-pnh 2025-04-25T13:51:44-04:00 daily 1.0 https://www.novartis.com/us-en/external-support-0 2026-07-22T14:43:55-04:00 daily 1.0 https://www.novartis.com/us-en/patients-and-caregivers/diseases/breast-cancer 2026-03-13T13:04:13-04:00 daily 1.0 https://www.novartis.com/us-en/patients-and-caregivers/diseases/sjogrens-disease 2025-10-21T09:10:27-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team 2026-06-16T14:45:06-04:00 daily 1.0 https://www.novartis.com/us-en/text-message-communications-terms-conditions 2026-01-09T08:54:42-05:00 daily 1.0 https://www.novartis.com/us-en/radioligand-therapy-production-carlsbad-california 2026-05-07T09:56:14-04:00 daily 1.0 https://www.novartis.com/us-en/radioligand-therapy-production-denton-texas 2026-05-14T14:24:25-04:00 daily 1.0 https://www.novartis.com/us-en/biologics-production-14TW-durham-north-carolina 2026-05-07T10:01:26-04:00 daily 1.0 https://www.novartis.com/us-en/gene-therapy-production-tricenter-durham-north-carolina 2026-05-07T10:03:53-04:00 daily 1.0 https://www.novartis.com/us-en/radioligand-therapy-production-indianapolis-indiana 2026-05-07T09:57:40-04:00 daily 1.0 https://www.novartis.com/us-en/radiologand-therapy-production-millburn-new-jersey 2026-05-07T09:59:04-04:00 daily 1.0 https://www.novartis.com/us-en/cell-therapy-production-morris-plains-new-jersey 2026-05-07T10:05:06-04:00 daily 1.0 https://www.novartis.com/us-en/small-molecule-production-morrisville-north-carolina 2026-05-07T10:00:26-04:00 daily 1.0 https://www.novartis.com/us-en/radioligand-therapy-production-winter-park-florida 2026-05-07T10:03:07-04:00 daily 1.0 https://www.novartis.com/us-en/biomedical-research-organization-cambridge-massachusetts 2026-05-07T10:07:49-04:00 daily 1.0 https://www.novartis.com/us-en/biomedical-research-center-san-diego-california 2026-05-07T10:06:00-04:00 daily 1.0 https://www.novartis.com/us-en/news 2026-03-05T15:04:13-05:00 daily 0.5 https://www.novartis.com/us-en/about 2026-03-05T13:01:25-05:00 daily 0.5 https://www.novartis.com/us-en/home 2026-07-21T14:30:28-04:00 daily 0.5 https://www.novartis.com/us-en/esg 2026-03-05T13:14:51-05:00 daily 0.5 https://www.novartis.com/us-en/patients-and-caregivers 2026-03-05T15:06:06-05:00 daily 0.5 https://www.novartis.com/us-en/healthcare-professionals 2026-07-21T15:54:59-04:00 daily 0.5 https://www.novartis.com/us-en/about/inclusion-and-belonging 2026-02-04T14:39:33-05:00 daily 0.5 https://www.novartis.com/us-en/about/novartis-us 2026-03-05T04:27:14-05:00 daily 0.5 https://www.novartis.com/us-en/esg/ethics-risk-and-compliance 2025-01-30T06:27:39-05:00 daily 0.5 https://www.novartis.com/us-en/esg/corporate-responsibility 2025-02-20T10:41:29-05:00 daily 0.5 https://www.novartis.com/us-en/esg/corporate-responsibility/beacon-hope 2025-06-13T11:49:58-04:00 daily 0.5 https://www.novartis.com/us-en/clinicaltrials/cardio-renal-metabolism/renal/NCT04181762-us-en 2026-03-05T04:29:45-05:00 daily 0.5 https://www.novartis.com/us-en/clinicaltrials/respiratory-allergy/foodallergy/NCT04984876-us-es 2026-03-05T04:43:59-05:00 daily 0.5 https://www.novartis.com/us-en/clinicaltrials/immunology/SLE/NCT05639114-NCT05624749 2025-06-25T12:18:01-04:00 daily 0.5 https://www.novartis.com/us-en/clinicaltrials/immunology/osteoarthritis/NCT04886258-NCT04814368-NCT05462990-es 2026-03-05T04:45:21-05:00 daily 0.5 https://www.novartis.com/us-en/clinicaltrials/immunology/RCT/NCT05722522-NCT05758415 2026-03-05T04:46:43-05:00 daily 0.5 https://www.novartis.com/us-en/clinicaltrials/immunology/LN/NCT05126277 2026-03-05T04:47:56-05:00 daily 0.5 https://www.novartis.com/us-en/patients-and-caregivers/diseases 2026-09-08T13:29:09-04:00 daily 0.5 https://www.novartis.com/us-en/patients-and-caregivers/patient-resources 2026-07-21T15:49:11-04:00 daily 0.5 https://www.novartis.com/us-en/clinicaltrials/immunology/CINDU/NCT05976243 2025-01-31T11:35:31-05:00 daily 0.5 https://www.novartis.com/us-en/clinicaltrials/hematology/ITPWAIHA/NCT05653349-NCT05653219-NCT05648968-us-es 2026-03-05T04:50:11-05:00 daily 0.5 https://www.novartis.com/us-en/healthcare-professionals/personalized-and-precision-medicine 2026-06-30T13:55:56-04:00 daily 0.5 https://www.novartis.com/us-en/healthcare-professionals/health-information-technology-resources 2026-03-04T16:11:13-05:00 daily 0.5 https://www.novartis.com/us-en/about/therapeutic-areas 2026-03-05T04:51:33-05:00 daily 0.5 https://www.novartis.com/us-en/about/therapeutic-areas/oncology 2026-04-07T13:28:13-04:00 daily 0.5 https://www.novartis.com/us-en/about/nfl-partnership 2026-06-08T12:39:01-04:00 daily 0.5 https://www.novartis.com/us-en/about/investing-americas-health 2026-07-15T13:41:49-04:00 daily 0.5 https://www.novartis.com/us-en/about/therapeutic-areas/immunology 2026-07-24T11:40:24-04:00 daily 0.5 https://www.novartis.com/us-en/patients-and-caregivers/diseases/cardiovascular-disease 2026-09-08T16:00:36-04:00 daily 0.5 https://www.novartis.com/us-en/about/therapeutic-areas/cardiovascular-renal-and-metabolic 2026-08-21T13:56:40-04:00 daily 0.5 https://www.novartis.com/us-en/about/radioligand-therapy 2026-04-09T16:37:04-04:00 daily 0.5 https://www.novartis.com/us-en/patients-and-caregivers/diseases/kidney-disease 2026-08-21T13:48:48-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-corrective-action-certain-blister-packages-sandimmune-and-neoral-100-mg-soft-gelatin-capsules-us-due-failure-meet-child-resistant-packaging-requirements 2022-04-04T03:14:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-three-pivotal-trials-showing-durable-and-potent-efficacy-inclisiran-investigational-first-class-sirna-cholesterol-lowering-therapy 2022-04-04T03:09:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-analysis-further-shows-durable-and-potent-ldl-c-reduction-inclisiran-investigational-first-class-sirna-cholesterol-lowering-treatment 2022-04-04T02:24:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-analysis-further-showed-durable-and-potent-ldl-c-reduction 2022-03-13T11:20:33-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-and-novartis-us-foundation-establish-usd-5-million-us-covid-19-community-response-fund 2022-07-25T11:29:50-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-us-foundation-supports-telehealth-programs-provide-access-care-new-jerseys-most-vulnerable-communities 2022-03-29T04:00:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-met-inhibitor-tabrectatm-metastatic-non-small-cell-lung-cancer-metex14 2022-03-29T08:12:54-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-shows-overall-survival-benefit-hrher2-advanced-breast-cancer-consistent-findings-patients-more-aggressive-disease 2022-03-29T03:57:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-late-breaking-ofatumumab-data-ean-underscoring-commitment-advancing-treatment-relapsing-forms-multiple-sclerosis-rms 2022-03-29T08:15:09-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-long-term-relapse-free-survival-benefit-high-risk-stage-iii-melanoma-patients-treated-tafinlar-mekinist-following-surgery 2022-03-29T08:18:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/us-fda-approves-updated-novartis-beovu-label-include-additional-safety-information 2022-03-29T08:20:08-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-manufactures-and-donates-27000-units-hand-sanitizer-new-york-state 2022-03-29T08:24:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-receives-fda-approval-new-indication-treat-active-non-radiographic-axial-spondyloarthritis 2022-03-29T08:28:20-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ilaris-canakinumab-receives-fda-approval-new-indication-treat-adult-onset-stills-disease-aosd 2022-03-29T08:31:29-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-entresto-sacubitrilvalsartan-patients-heart-failure-preserved-ejection-fraction-hfpef 2022-03-29T08:34:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-phase-iii-asclepios-trials-demonstrating-superior-efficacy-ofatumumab-patients-relapsing-multiple-sclerosis 2022-03-29T08:00:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-xolair-omalizumab-prefilled-syringe-self-administration-across-all-indications 2022-03-29T09:10:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-kesimpta-ofatumumab-first-and-only-self-administered-targeted-b-cell-therapy-patients-relapsing-multiple-sclerosis 2022-03-29T08:38:12-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-pso-know-podcast-series-hosted-music-icon-cyndi-lauper 2022-03-29T08:39:48-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-parallax-data-provides-further-evidence-potential-benefit-entresto-patients-hfpef 2022-03-29T08:41:12-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-analysis-shows-high-consistency-lowering-ldl-c-individual-response-investigational-inclisiran 2022-03-29T08:42:29-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-data-actrims-ectrims-effects-treatment-mayzent-siponimod-studied-disability-progression-and-cognitive-processing-speed-patients-progressing-relapsing-multiple-sclerosis 2022-03-29T08:43:42-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-data-actrims-ectrims-kesimpta-ofatumumab-newly-diagnosed-treatment-naive-adults-relapsing-multiple-sclerosis 2022-03-29T08:45:27-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-us-foundation-commits-25m-improve-health-equity-reducing-health-disparities-us 2022-03-29T08:48:51-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-step-programtm-awards-nearly-375000-patient-advocacy-organizations-their-innovative-solutions-biomarker-testing-now-accepting-proposals-caregiving-cancer-and-certain-blood-disorders 2022-03-29T08:51:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-five-year-data-reinforce-safety-and-efficacy-profile-aimovig-erenumab-aooe-adult-patients-episodic-migraine 2022-03-29T09:07:56-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-shows-early-synovitis-reduction-patients-psoriatic-arthritis-first-its-kind-study 2022-03-29T08:59:08-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-analyses-investigational-inclisiran-demonstrate-consistently-effective-and-sustained-ldl-c-reduction-month-17-regardless-age-and-gender 2022-03-29T09:02:47-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-data-ash-reinforce-breadth-novartis-hematology-portfolio-across-multiple-blood-cancers-and-serious-hematologic-diseases 2022-03-29T09:05:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-adults-nasal-polyps 2022-03-29T09:10:21-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-and-amgen-partner-karamo-brown-support-and-empower-people-living-migraine 2022-03-29T10:13:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-stamp-inhibitor-asciminib-abl001-shows-superior-mmr-rate-bosulif-chronic-myeloid-leukemia-trial 2022-03-29T10:09:39-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-demonstrates-nearly-five-years-median-overall-survival-metastatic-breast-cancer 2022-03-29T10:15:12-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-positive-fda-advisory-committee-recommendation-use-entresto-treat-patients-hfpef 2022-03-29T10:37:59-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ligelizumab-qge031-receives-fda-breakthrough-therapy-designation-patients-chronic-idiopathic-urticaria-ciu 2022-03-29T10:34:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-entresto-granted-expanded-indication-chronic-heart-failure-fda 2022-07-25T11:38:27-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-awards-450000-eight-nonprofit-organizations-through-step-programtm 2022-03-29T10:48:05-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-xolair-omalizumab-self-injection-prefilled-syringe-across-all-indications-appropriate-patients 2022-03-29T10:50:51-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-data-aan-novel-combination-biomarker-may-predict-disability-worsening-secondary-progressive-multiple-sclerosis 2022-03-29T10:54:29-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/kesimpta-ofatumumab-data-aan-showed-reduction-disability-progression-independent-relapse-activity-newly-diagnosed-patients-rms 2022-03-29T11:00:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-data-aad-vmx-shows-improvement-skin-symptoms-and-quality-life-was-maintained-one-year-children-moderate-severe-plaque-psoriasis 2022-03-29T11:00:39-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-phase-iii-beovu-data-show-potential-fluid-resolution-more-diabetic-macular-edema-patients-fewer-injections-versus-aflibercept 2022-03-29T11:06:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-commits-addressing-racial-disparities-breast-cancer-screening-treatment-and-care 2022-03-29T11:05:57-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-reports-one-year-results-phase-iii-merlin-study-evaluating-beovu-every-four-week-dosing-and-provides-update-beovu-clinical-program 2022-03-29T10:09:33-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-receives-fda-approval-treatment-children-and-adolescents-moderate-severe-plaque-psoriasis 2022-03-29T10:09:26-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kymriah-pivotal-trial-demonstrates-strong-response-rates-and-remarkable-safety-profile-relapsed-or-refractory-follicular-lymphoma 2022-03-29T10:08:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-reports-longest-median-overall-survival-postmenopausal-hrher2-metastatic-breast-cancer-patients 2022-03-29T10:08:44-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-checkpoint-inhibitor-tislelizumab-met-primary-endpoint-overall-survival-pivotal-phase-iii-trial-esophageal-cancer-after-systemic-therapy 2022-03-29T10:08:02-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-tabrecta-first-published-overall-survival-and-updated-overall-response-data-patients-metex14-metastatic-nsclc 2022-03-29T10:07:50-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pledges-10-year-commitment-morehouse-school-medicine-26-historically-black-colleges-universities-medical-schools-and-other-leading-organizations-co-create-effective-measurable-solutions-health-equity 2022-03-29T10:19:17-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-positive-results-from-phase-iii-trials-beovu-diabetic-macular-edema-including-dosing-intervals-16-weeks 2022-03-29T10:16:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-meet-pros-raise-awareness-and-support-education-pik3ca-related-overgrowth-spectrum-pros 2022-03-29T10:31:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-findings-from-real-world-study-alpelisib-demonstrating-clinical-benefit-people-pik3ca-related-overgrowth-spectrum-pros 2022-03-29T10:34:36-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-kisqali-data-showing-longest-median-overall-survival-ever-reported-hrher2-advanced-breast-cancer 2022-03-29T10:38:03-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-and-ema-filing-acceptances-beovu-patients-diabetic-macular-edema 2022-03-29T10:58:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/kesimpta-ofatumumab-data-ectrims-highlights-preservation-igg-levels-and-safety-experience-over-extended-exposure-35-years-people-living-relapsing-multiple-sclerosis 2022-03-29T11:02:35-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-scemblix-asciminib-novel-mechanism-action-treatment-chronic-myeloid-leukemia 2022-03-29T11:09:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-iptacopan-meets-primary-endpoints-phase-ii-study-rare-kidney-disease-c3-glomerulopathy-c3g 2022-03-29T11:13:36-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-positive-phase-iii-results-cosentyx-children-active-enthesitis-related-arthritis-era-and-juvenile-psoriatic-arthritis-jpsa-acr-2021 2022-03-29T11:20:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-kisqali-data-shows-consistent-overall-survival-benefit-across-genomic-and-clinical-subtypes-interest-hrher2-metastatic-breast-cancer 2022-03-29T11:27:32-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-highlight-efficacy-piqray-hrher2-metastatic-breast-cancer-pik3ca-driver-mutation-immediately-post-cdk46i 2022-03-29T11:32:03-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kymriah-demonstrates-strong-responses-high-risk-patients-relapsed-or-refractory-follicular-lymphoma-extended-study-follow 2022-03-29T11:37:29-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-t-chargetm-next-generation-car-t-platform-first-human-data-ash-2021 2022-03-29T11:33:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-leqvio-inclisiran-first-class-sirna-lower-cholesterol-and-keep-it-low-two-doses-year 2022-07-21T12:09:56-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-receives-fda-approval-treatment-children-and-adolescents-enthesitis-related-arthritis-and-psoriatic-arthritis 2022-03-29T11:25:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-177lu-psma-617-significantly-improves-overall-survival-and-radiographic-progression-free-survival-men-metastatic-castration-resistant-prostate-cancer-phase-iii-vision-study 2022-03-29T11:20:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-kymriah-car-t-cell-therapy-adult-patients-relapsed-or-refractory-follicular-lymphoma 2022-07-07T10:23:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-vijoice-alpelisib-first-and-only-treatment-select-patients-pik3ca-related-overgrowth-spectrum-pros 2022-07-07T10:23:48-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pluvictotm-approved-fda-first-targeted-radioligand-therapy-treatment-progressive-psma-positive-metastatic-castration-resistant-prostate-cancer 2022-07-07T10:23:48-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-177lu-psma-617-significantly-improves-overall-survival-and-radiographic-progression-free-survival-men-metastatic-castration-resistant-prostate-cancer-phase-iii-vision-study-0 2022-07-07T10:23:57-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-analysis-further-showed-durable-and-potent-ldl-c-reduction-inclisiran-investigational-first-class-sirna-cholesterol-lowering-treatment 2022-07-07T10:24:24-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-met-inhibitor-capmatinib-inc280-first-potential-treatment-metex14-mutated-advanced-non-small-cell-lung-cancer-granted-priority-fda-review 2022-07-07T10:24:27-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/public-private-collaboration-commits-accelerate-access-health-services-africa-reaching-17-million-people 2022-07-07T10:24:27-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-xolair-omalizumab-treatment-nasal-polyps 2022-07-07T10:24:27-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kymriah-demonstrates-consistent-efficacy-and-safety-outcomes-us-patients-when-used-real-world-setting 2022-07-07T10:24:30-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-medicine-adakveo-crizanlizumab-tmca-approved-fda-reduce-frequency-pain-crises-individuals-living-sickle-cell-disease 2022-07-07T10:24:30-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-pso-work-music-icon-cyndi-lauper-bring-life-impact-psoriasis-can-have-workplace 2022-07-07T10:24:30-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-step-programtm-now-accepting-submissions-proposals-address-unmet-patient-needs-cancer-biomarker-testing 2022-07-07T10:24:33-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-beovu-offering-wet-amd-patients-vision-gains-and-greater-fluid-reductions-vs-aflibercept 2022-07-07T10:24:33-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-positive-52-week-prevent-data-confirm-cosentyx-efficacy-addressing-entire-axspa-spectrum 2022-07-07T10:24:33-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-presents-new-data-epns-continuing-show-significant-therapeutic-benefit-zolgensma-prolonging-event-free-survival-now-5-years-age-patients-spinal-muscular-atrophy-sma-type-1 2022-07-07T10:24:36-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/entresto-improved-measures-heart-structure-and-function-hfref-patients-new-novartis-study-additional-data-complement-findings 2022-07-07T10:24:36-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-celebrity-interior-designer-nate-berkus-launch-my-home-sight-program-empowering-people-wet-amd-live-more-independently-home 2022-07-07T10:24:36-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-accepts-file-and-accelerates-review-novartis-sickle-cell-disease-medicine-crizanlizumab-seg101 2022-07-07T10:24:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-offers-free-genetic-mutation-testing-program-advanced-melanoma-patients-results-can-help-doctors-and-patients-making-cancer-treatment-decisions 2022-07-07T10:24:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/long-term-survival-benefit-shown-metastatic-melanoma-patients-treated-novartis-tafinlar-mekinist 2022-07-07T10:24:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-shows-growing-strength-lung-cancer-innovation-new-capmatinib-investigational-data-and-novel-canakinumab-clinical-trials 2022-07-07T10:24:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-announces-innovative-zolgensma-gene-therapy-access-programs-us-payers-and-families 2022-07-07T10:24:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-receives-fda-approval-zolgensma-first-and-only-gene-therapy-pediatric-patients-spinal-muscular-atrophy-sma 2022-07-07T10:24:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-asco-and-eha-demonstrate-novel-approaches-reimagining-medicine-cancer-and-serious-blood-disorders 2022-07-07T10:24:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/five-nonprofit-organizations-receive-250000-through-novartis-step-programtm-support-sickle-cell-patient-initiatives 2022-07-07T10:24:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-issues-voluntary-nationwide-recall-promacta-125-mg-oral-suspension-due-potential-peanut-contamination 2022-07-07T10:24:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-avexis-data-aan-showed-long-term-durability-zolgensma-patients-spinal-muscular-atrophy-sma-type-1 2022-07-07T10:24:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-presented-robust-data-aan-demonstrating-efficacy-zolgensma-broad-spectrum-spinal-muscular-atrophy-sma-patients 2022-07-07T10:24:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-and-priority-review-brolucizumab-rth258-patients-wet-amd 2022-07-07T10:24:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-expands-world-leading-gene-therapy-manufacturing-capacity-purchase-advanced-biologics-therapy-manufacturing-campus-longmont-colorado 2022-07-07T10:24:48-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-mayzent-siponimod-first-oral-drug-treat-secondary-progressive-ms-active-disease 2022-07-07T10:24:48-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-late-breaking-data-further-support-initiation-entresto-hospital-and-first-choice-systolic-heart-failure-therapy-stabilized-patients 2022-07-07T10:24:48-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-show-psoriasis-patients-treated-cosentyx-reported-improvements-quality-life-measures-early-week-4 2022-07-07T10:24:51-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-therapy-crizanlizumab-seg101-receives-fda-breakthrough-therapy-designation-prevention-vaso-occlusive-crises-sickle-cell-disease 2022-07-07T10:24:51-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-demonstrates-consistent-efficacy-and-tolerability-kisqali-combination-therapy-hrher2-advanced-breast-cancer-patients-difficult-treat-visceral-disease 2022-07-07T10:24:51-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-byl719-alpelisib-plus-fulvestrant-consistently-improved-pfs-patients-pik3ca-mutated-hrher2-advanced-breast-cancer-new-solar-1-analyses 2022-07-07T10:24:54-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/real-world-data-show-novartis-drug-promacta-improves-outcomes-itp-patients-compared-other-second-line-therapies 2022-07-07T10:24:54-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-longer-term-analyses-from-pivotal-kymriah-trials-showed-durable-responses-are-maintained-patients-advanced-blood-cancers 2022-07-07T10:24:54-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-crizanlizumab-seg101-data-analysis-sickle-cell-disease-and-investment-sentry-clinical-program 2022-07-07T10:24:57-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-drug-promacta-first-line-saa-and-grants-breakthrough-therapy-designation-additional-new-indication 2022-07-07T10:24:57-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-fund-five-innovative-ideas-support-patients-and-sickle-cell-community 2022-07-07T10:24:57-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-study-supports-entresto-foundational-hfref-therapy-and-hospital-initiation-appropriate-stabilized-heart-failure-patients 2022-07-07T10:25:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-ash-and-sabcs-show-strength-pipeline-and-portfolio-hematology-and-oncology 2022-07-07T10:25:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-wins-esteemed-prix-galien-foundation-best-biotechnology-product-award-car-t-cell-therapy-kymriah 2022-07-07T10:25:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/two-year-data-novartis-brolucizumab-reaffirm-superiority-versus-aflibercept-reducing-retinal-fluid-patients-namd 2022-07-07T10:25:03-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-cosentyx-data-demonstrating-long-term-response-and-safety-ankylosing-spondylitis 2022-07-07T10:25:03-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-analysis-shows-crizanlizumab-seg101-increased-number-patients-free-sickle-cell-pain-crises-vs-placebo-during-sustain-study 2022-07-07T10:25:03-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-siponimod-baf312-first-and-only-oral-drug-shown-delay-disability-progression-typical-spms-patients 2022-07-07T10:25:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-recording-artist-and-actress-jordin-sparks-and-scdaa-launch-generation-s-inspiring-new-sickle-cell-storytelling-project 2022-07-07T10:25:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-landmark-paradigms-study-demonstrating-significant-benefit-gilenya-children-and-adolescents-relapsing-multiple-sclerosis 2022-07-07T10:25:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-now-first-and-only-cdk46-inhibitor-indicated-us-first-line-therapy-specifically-premenopausal-women-and-initial-therapy-fulvestrant-postmenopausal-women 2022-07-07T10:25:09-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-galaxies-hope-app-digital-experience-neuroendocrine-tumor-net-cancer-community 2022-07-07T10:25:09-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/sandoz-inc-and-its-affiliate-novartis-pharmaceuticals-corporation-voluntarily-recall-select-blister-packages-products-us-due-packaging-requirements-child-resistance 2022-07-07T10:25:09-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-and-amgen-highlight-findings-from-large-global-patient-survey-revealing-worldwide-approximately-60-employed-people-migraine-missed-average-week-work-month 2022-07-07T10:25:12-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-funding-patient-advocacy-initiatives-support-and-empower-metastatic-breast-cancer-community 2022-07-25T11:29:18-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-inclusion-new-evidence-cosentyx-inhibits-progression-joint-structural-damage-psoriatic-arthritis 2022-07-07T10:25:12-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-juliet-trial-kymriah-demonstrates-more-one-year-durability-responses-adults-relapsed-or-refractory-dlbcl 2022-07-07T10:25:14-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-survey-uncovers-real-world-impact-immune-thrombocytopenia-or-itp-rare-blood-disease-patients-quality-life 2022-07-07T10:25:14-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/third-novartis-phase-iii-trial-shows-kisqali-combination-therapy-significantly-improves-pfs-hrher2-advanced-breast-cancer 2022-07-07T10:25:14-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-expedites-review-novartis-drug-promacta-first-line-severe-aplastic-anemia-saa 2022-07-07T10:25:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/patient-reported-outcomes-tool-revealed-significant-improvement-symptom-frequency-and-quality-life-domains-entresto 2022-07-07T10:25:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-and-amgen-announce-fda-approval-aimovigtm-erenumab-aooe-novel-treatment-developed-specifically-migraine-prevention 2022-07-07T10:25:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-asco-and-eha-reinforce-companys-commitment-reimagining-cancer 2022-07-07T10:25:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-teams-venus-williams-tennis-champion-and-dry-eye-sufferer-launch-systane-complete-eye-drops 2022-07-07T10:25:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-gilenya-first-disease-modifying-therapy-pediatric-relapsing-multiple-sclerosis 2022-07-07T10:25:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/kymriah-tisagenlecleucel-first-class-car-t-therapy-from-novartis-receives-second-fda-approval-treat-appropriate-rr-patients-large-b-cell-lymphoma 2022-07-07T10:25:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-introduces-air-optix-colors-contact-lenses-gemstone-collection-creating-new-ways-enhance-and-play-eye-color 2022-07-20T16:07:02-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-phase-iii-data-brolucizumab-demonstrate-reliability-12-week-treatment-interval 2022-07-07T10:25:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-focalview-app-providing-opportunity-patients-participate-ophthalmology-clinical-trials-from-home 2022-07-07T10:25:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/phase-iii-data-lancet-show-novartis-siponimod-significantly-improved-outcomes-patients-secondary-progressive-ms 2022-07-07T10:25:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-data-show-cosentyx-improved-quality-life-over-5-years-two-thirds-patients-moderate-severe-plaque-psoriasis 2022-07-07T10:25:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-cosentyx-label-update-include-moderate-severe-scalp-psoriasis 2022-07-07T10:25:28-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-data-reinforces-superiority-cosentyx-versus-stelara-achieving-skin-clearance-psoriasis-patients 2022-07-07T10:25:28-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-promacta-receives-fda-breakthrough-therapy-designation-first-line-use-severe-aplastic-anemia-saa 2022-07-07T10:25:28-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-received-fda-breakthrough-therapy-designation-initial-endocrine-based-treatment-premenopausal-women-hrher2-advanced-breast-cancer 2022-07-07T10:25:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-multiple-sclerosis-therapy-fingolimod-granted-fda-breakthrough-therapy-designation-pediatric-ms 2022-07-07T10:25:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-crizanlizumab-shown-prolong-time-patients-first-sickle-cell-pain-crisis-subgroup-analysis-sustain-study 2022-07-07T10:25:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/primary-analysis-results-from-novartis-pivotal-juliet-trial-show-kymriahtm-tisagenlecleucel-sustained-complete-responses-six-months-adults-rr-dlbcl-difficult-treat-cancer 2022-07-07T10:25:34-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-initiates-study-evaluating-impact-higher-dosing-cosentyx-patients-ankylosing-spondylitis 2022-07-07T10:25:34-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-first-and-only-cdk46-inhibitor-show-superior-median-pfs-compared-oral-endocrine-therapy-first-line-treatment-prospective-randomized-phase-iii-trial-dedicated-premenopausal-women-hrher2-advanced-breast-cancer 2022-07-07T10:25:34-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-data-sabcs-across-broad-range-breast-cancer-patient-populations-combination-treatments-and-lines-therapy 2022-07-07T10:25:37-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-canakinumab-acz885-reduced-cardiovascular-risk-25-subgroup-cantos-phase-iii-trial-participants 2022-07-07T10:25:37-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-brolucizumab-rth258-demonstrates-superiority-versus-aflibercept-key-secondary-endpoint-measures-disease-activity-namd-leading-cause-blindness 2022-07-07T10:25:37-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-study-data-demonstrating-cosentyx-reduced-signs-and-symptoms-psoriatic-arthritis-while-inhibiting-progression-joint-structural-damage 2022-07-07T10:25:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-data-ash-patients-serious-blood-disorders-lymphoma-leukemia-and-sickle-cell-disease 2022-07-07T10:25:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pivotal-data-show-children-and-adolescents-relapsing-ms-had-82-lower-relapse-rate-fingolimod-vs-interferon-beta-1a 2022-07-07T10:25:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-collaborates-pop-icon-cyndi-lauper-release-new-song-honor-world-psoriasis-day 2022-07-07T10:25:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-promacta-shows-long-term-disease-control-chronicpersistent-immune-thrombocytopenia-itp 2022-07-07T10:25:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-dailies-teams-us-olympians-world-class-gymnast-laurie-hernandez-and-soccer-star-tobin-heath-launch-invisible-edge-campaign 2022-07-07T10:25:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-actress-producer-and-activist-eva-longoria-launch-kiss-4-mbctm-generate-research-funding-and-support-metastatic-breast-cancer-community 2022-07-07T10:25:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-sets-new-benchmark-psoriasis-robust-5-year-sustained-efficacy-and-safety-phase-iii-data 2022-07-07T10:25:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/multimedia-assets-now-available-novartis-receives-first-ever-fda-approval-car-t-cell-therapy-kymriahtm-tisagenlecleucel-ctl019-children-and-young-adults-b-cell-all-refractory-or-has-relapsed-least-twice 2022-07-07T10:25:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-first-ever-fda-approval-car-t-cell-therapy-kymriahtm-tisagenlecleucel-ctl019-children-and-young-adults-b-cell-all-refractory-or-has-relapsed-least-twice 2022-07-07T10:25:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-first-large-scale-research-study-multiple-sclerosis-allows-participants-contribute-from-smartphones 2022-07-07T10:25:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-accepts-biologics-license-application-amg-334-erenumab-important-regulatory-milestone-novartis 2022-07-07T10:25:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-confirms-5-year-data-first-and-only-fully-human-il-17a-inhibitor-cosentyx-reinforcing-sustained-efficacy-and-safety-profile-psoriasis 2022-07-07T10:25:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pivotal-ctl019-6-month-follow-data-show-durable-remission-rates-children-young-adults-rr-b-cell-all 2022-07-07T10:25:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-interim-results-from-global-pivotal-ctl019-trial-show-durable-complete-responses-adults-rr-dlbcl 2022-07-07T10:25:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-first-its-kind-kisqali-femara-co-pack-initial-treatment-hrher2-advanced-or-metastatic-breast-cancer 2022-07-07T10:25:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-expands-global-collaboration-amgen-commercialize-first-class-amg-334-erenumab-program-migraine-prevention-us-and-canada 2022-07-07T10:25:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-car-t-cell-therapy-ctl019-receives-fda-breakthrough-therapy-designation-treatment-adult-patients-rr-dlbcl 2022-07-07T10:25:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-first-car-t-cell-therapy-bla-pediatric-and-young-adult-patients-rr-b-cell-all-granted-fda-priority-review 2022-07-07T10:25:58-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-analysis-shows-novartis-entresto-improves-glycemic-control-reduced-ejection-fraction-heart-failure-patients-diabetes 2022-07-07T10:25:58-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-shows-almost-all-psoriasis-patients-rapidly-regain-skin-clearance-following-treatment-pause 2022-07-07T10:25:58-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-receives-us-fda-approval-acrysof-iq-restor-30d-multifocal-toric-intraocular-lens-cataract-patients 2022-07-07T10:26:01-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-out-licenses-three-copd-products-us 2022-07-07T10:26:01-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-results-from-first-global-registration-trial-ctl019-pediatric-and-young-adult-patients-rr-b-all 2022-07-07T10:26:01-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-analysis-novartis-entresto-data-shows-long-term-benefits-heart-failure-readmissions-and-total-cardiovascular-deaths 2022-07-07T10:26:04-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-introduces-new-air-optix-plus-hydraglyde-monthly-replacement-contact-lenses-american-academy-optometry-annual-meeting 2022-07-07T10:26:04-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-partners-prominent-us-health-advocacy-organizations-launch-first-social-networking-platform-heart-failure-patients-and-their-loved-ones 2022-07-07T10:26:04-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-late-breaking-data-show-cosentyx-continues-deliver-high-skin-clearance-majority-psoriasis-patients-four-years 2022-07-07T10:26:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-three-new-fda-approvals-expanded-use-ilaris-patients-rare-periodic-fever-syndrome-conditions 2022-07-07T10:26:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/important-new-analysis-shows-novartis-entresto-associated-higher-relative-health-related-quality-life-scores-among-hfref-patients 2022-07-07T10:26:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-baf312-reduced-risk-disability-progression-pivotal-phase-iii-study-secondary-progressive-ms-patients 2022-07-07T10:26:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-finds-relapsing-ms-patients-gilenya-had-greater-treatment-retention-and-satisfaction-rates-vs-injectable-dmts 2022-07-07T10:26:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-pediatric-allergic-asthma 2022-07-07T10:26:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/largest-global-psoriasis-survey-shows-85-us-respondents-faced-social-stigma-discrimination-and-humiliation-because-their-skin 2022-07-07T10:26:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/timely-use-novartis-entresto-could-prevent-or-postpone-over-28000-us-deaths-year-among-hfref-patients-according-expert-analysis-jama-cardiology 2022-07-07T10:26:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-show-gilenya-had-significantly-greater-patient-retention-compared-idmts-relapsing-remitting-ms 2022-07-07T10:26:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/media-statement-leading-us-cardiology-societies-strongly-recommend-entresto-new-standard-care-treatment-earlier-expected-joint-update-clinical-practice-guidelines-heart-failure 2022-07-07T10:26:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/media-statement-fortihfy-global-clinical-program-entresto 2022-07-07T10:26:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-three-fda-breakthrough-therapy-designations-ilaris-treat-rare-types-periodic-fever-syndromes 2022-07-07T10:26:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-analyses-show-novartis-entrestotm-reduced-cardiovascular-death-or-hospitalization-heart-failure-consistently-benefitting-patients-reduced-ejection-fraction-hfref-regardless-prior-heart-failure-hospital-admissions-or-background 2022-07-07T10:26:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-data-show-cosentyx-demonstrated-sustained-superiority-skin-clearance-pasi-90-versus-stelara-week-52 2022-07-07T10:26:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-new-indication-novartis-drug-afinitor-progressive-nonfunctional-gi-and-lung-neuroendocrine-tumors-net 2022-07-07T10:26:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-two-new-fda-approvals-cosentyx-secukinumab-treat-patients-ankylosing-spondylitis-and-psoriatic-arthritis 2022-07-07T10:26:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-publication-two-landmark-studies-nejm-demonstrating-efficacy-cosentyx-patients-ankylosing-spondylitis 2022-07-07T10:26:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-new-ctl019-phase-ii-data-demonstrating-93-complete-remission-pediatric-patients-rr-all 2022-07-07T10:26:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-ctl019-study-data-demonstrating-overall-response-adult-patients-certain-types-lymphoma 2022-07-07T10:26:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-finalizes-settlement-agreement-resolving-civil-suit-filed-us-attorneys-office-southern-district-new-york 2022-07-07T10:26:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-heart-failure-medicine-entrestotm-substantially-cuts-30-day-hospital-readmissions-new-post-hoc-analysis-shows 2022-07-07T10:26:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/80-ankylosing-spondylitis-patients-treated-cosentyx-show-no-spinal-x-ray-progression-shown-novartis-new-two-year-observational-data 2022-07-07T10:26:28-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/approximately-80-psoriatic-arthritis-patients-treated-cosentyx-saw-no-progression-joint-damage-shown-novartis-new-two-year-observational-data 2022-07-07T10:26:28-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-new-novartis-dual-combination-bronchodilator-utibrontm-neohaler-patients-chronic-obstructive-pulmonary-disease 2022-07-07T10:26:28-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-clarification-specialty-pharmacy-settlement-principle-announcement 2022-07-07T10:26:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-secukinumab-phase-iii-data-confirming-significant-efficacy-patients-psoriatic-arthritis 2022-07-07T10:26:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/patients-aggressive-form-melanoma-lived-more-two-years-average-when-taking-novartis-therapies-tafinlar-mekinist 2022-07-07T10:26:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-novartis-access-portfolio-affordable-medicines-treat-chronic-diseases-lower-income-countries 2022-07-07T10:26:34-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-drug-odomzo-sonidegib-locally-advanced-basal-cell-carcinoma-labcc-form-skin-cancer 2022-07-07T10:26:34-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-heart-failure-medicine-lcz696-approved-fda-reduce-risk-cardiovascular-death-and-heart-failure-hospitalization-now-called-entrestotm-sacubitrilvalsartan 2022-07-07T10:26:34-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-data-wcd-shows-significant-efficacy-cosentyx-patients-psoriasis-palms-soles-feet-and-nails 2022-07-07T10:26:37-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-ctl019-data-showing-its-potential-treatment-specific-types-hard-treat-non-hodgkin-lymphoma 2022-07-07T10:26:37-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/combination-novartis-drugs-tafinlar-and-mekinist-shows-significant-survival-benefit-patients-metastatic-melanoma 2022-07-07T10:26:37-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-dual-bronchodilator-significantly-improved-lung-function-compared-single-bronchodilators-patients-moderate-severe-copd-phase-iii-studies 2022-07-07T10:26:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-jadenutm-simplify-treatment-administration-patients-chronic-iron-overload 2022-07-07T10:26:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-cosentyxtm-two-year-efficacy-and-safety-data-showing-sustainable-effect-psoriasis-patients 2022-07-07T10:26:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-data-show-more-cosentyxtm-treated-psoriasis-patients-achieved-clear-or-almost-clear-skin-pasi-90-compared-stelara 2022-07-07T10:26:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-heart-failure-medicine-lcz696-granted-fda-priority-review 2022-07-25T11:40:33-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-first-il-17a-antagonist-cosentyxtm-secukinumab-moderate-severe-plaque-psoriasis-patients 2022-07-07T10:26:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-signifor-lar-treat-patients-acromegaly-rare-and-life-threatening-hormonal-disorder 2022-07-07T10:26:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-new-ctl019-clinical-data-showing-complete-remissions-children-and-young-adults-relapsedrefractory-acute-lymphoblastic-leukemia 2022-07-07T10:26:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/nine-new-analyses-show-novartis-lcz696-could-change-course-heart-failure-patients 2022-07-07T10:26:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-first-il-17a-phase-iii-results-show-ain457-secukinumab-significantly-improves-psoriatic-arthritis-patients 2022-07-07T10:26:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ain457-secukinumab-showed-significant-symptom-improvement-two-pivotal-phase-iii-ankylosing-spondylitis-studies 2022-07-07T10:26:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-present-first-il-17a-phase-iii-data-ain457-secukinumab-psoriatic-arthritis-and-ankylosing-spondylitis-acr-2014 2022-07-07T10:26:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-multiple-sclerosis-advocate-and-musician-david-osmond-launch-ms-education-initiative-our-voice-songtm 2022-07-07T10:26:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-advisory-committee-unanimously-recommends-approval-ain457-secukinumab-patients-moderate-severe-plaque-psoriasis 2022-07-07T10:26:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-ctl019-data-published-nejm-demonstrating-efficacy-certain-patients-acute-lymphoblastic-leukemia-all 2022-07-07T10:26:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-afinitor-first-treatment-advanced-pancreatic-net-provide-overall-survival-more-35-years-phase-iii-trial 2022-07-07T10:26:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-heart-failure-medicine-lcz696-cut-cardiovascular-deaths-20-vs-ace-inhibitor-landmark-paradigm-hf-trial 2022-07-07T10:26:58-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-showcase-heart-failure-leadership-esc-congress-2014-results-new-first-its-type-medicine-lcz696 2022-07-07T10:26:58-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-two-pivotal-phase-iii-secukinumab-studies-demonstrating-statistically-significant-skin-clearance-psoriasis-patients 2022-07-07T10:26:58-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-personalized-cell-therapy-ctl019-receives-fda-breakthrough-therapy-designation 2022-07-07T10:27:01-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/pivotal-data-novartis-investigational-compound-lde225-show-marked-tumor-responses-advanced-basal-cell-carcinoma 2022-07-07T10:27:01-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-key-advances-cancer-research-asco-and-eha-from-four-new-pivotal-studies-lung-blood-and-skin-cancers 2022-07-07T10:27:01-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-signifor-lar-shows-superior-efficacy-acromegaly-patients-not-controlled-first-generation-somatostatin-analogues 2022-07-07T10:27:04-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-reports-new-phase-iii-data-showing-secukinumab-ain457-improved-moderate-severe-plaque-psoriasis-patients 2022-07-07T10:27:04-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-chronic-idiopathic-urticaria-ciu-form-chronic-hives 2022-07-07T10:27:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-stands-behind-medication-adherence-activities-and-reaffirms-commitment-patient-safety 2022-07-07T10:27:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-research-investigational-personalized-t-cell-therapy-ctl019-patients-forms-acute-and-chronic-leukemia 2022-07-07T10:27:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-hosts-competition-create-novel-mobile-solutions-heart-failure-caregivers 2022-07-07T10:27:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-data-effects-investigational-rlx030-kidney-blood-flow-chronic-heart-failure-patients 2022-07-07T10:27:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-exelon-patch-now-fda-approved-treat-patients-across-all-stages-alzheimers-disease 2022-07-07T10:27:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/tv-host-phil-keoghan-and-novartis-team-inspire-people-ms-through-innovative-tandem-cycling-campaign 2022-07-07T10:27:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/relapsing-ms-patients-more-satisfied-novartis-oral-drug-gilenya-standard-injectable-therapies-according-new-study-results-cmsc 2022-07-07T10:27:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-new-findings-advancing-care-patients-170-abstracts-breast-lung-and-blood-cancers-asco-and-eha 2022-07-07T10:27:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-disputes-allegations-two-us-government-lawsuits-and-looks-forward-fair-discussion-facts 2022-07-07T10:27:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-tobi-podhalertm-certain-cystic-fibrosis-patients-first-and-only-dry-powder-inhaled-antibacterial-us 2022-07-07T10:27:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-analysis-shows-novartis-drug-gilenya-significantly-reduced-rate-brain-volume-loss-across-three-large-phase-iii-studies 2022-07-07T10:27:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-reports-omalizumab-significantly-improved-chronic-idiopathic-urticaria-symptoms-patients-who-failed-standard-therapy 2022-07-07T10:27:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-zortress-first-over-decade-approved-fda-prevent-organ-rejection-adult-liver-transplant-patients 2022-07-07T10:27:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-exjade-first-treatment-approved-fda-chronic-iron-overload-patients-non-transfusion-dependent-thalassemia 2022-07-07T10:27:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/nejm-published-study-shows-novartis-compound-acz885-significantly-relieves-symptoms-patients-serious-form-childhood-arthritis 2022-07-07T10:27:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/multimedia-assets-novartis-drug-signifor-gains-fda-approval-first-medication-treat-cushings-disease-serious-endocrine-disorder 2022-07-07T10:27:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-signifor-gains-fda-approval-first-medication-treat-cushings-disease-serious-endocrine-disorder 2022-07-07T10:27:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-phase-iii-study-shows-rlx030-improved-symptoms-and-reduced-deaths-one-third-patients-acute-heart-failure 2022-07-07T10:27:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/leeza-gibbons-joins-novartis-improve-caregiving-experience-millions-americans-through-real-world-peer-advice-alzheimersdiseasecom 2022-07-07T10:27:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-emprende-una-campana-de-educacion-de-la-comunidad-hispana-de-ee-uu-sobre-la-enfermedad-de-alzheimer 2022-07-07T10:27:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-embarks-alzheimers-disease-educational-effort-us-hispanic-community 2022-07-07T10:27:28-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-advisory-committee-supports-use-tobramycin-inhalation-powder-from-novartis-patients-cystic-fibrosis 2022-07-07T10:27:28-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/higher-dose-novartis-drug-exelon-patch-approved-fda-patients-mild-moderate-alzheimers-disease 2022-07-07T10:27:28-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/npc-statement-comments-made-media-coverage-paycheck-fairness-act 2022-07-07T10:27:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/two-new-analyses-reinforce-consistent-efficacy-novartis-therapy-gilenya-across-wide-range-relapsing-ms-patients 2022-07-07T10:27:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/tv-host-phil-keoghan-and-professional-women-cyclists-join-novartis-raise-awareness-multiple-sclerosis 2022-07-07T10:27:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/higher-dose-novartis-drug-exelon-patch-showed-statistically-significantly-less-decline-function-alzheimers-vs-lower-dose 2022-07-07T10:27:35-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-extension-study-data-novartis-drug-gilenya-shows-patients-successfully-treated-7-years-relapsing-ms 2022-07-07T10:27:35-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-update-united-states-prescribing-information-ms-therapy-gilenya-following-fda-review 2022-07-07T10:27:35-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-expands-transplant-portfolio-hecoria-first-generic-tacrolimus-can-be-prescribed-brand-name 2022-07-07T10:27:39-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-arcaptatm-neohalertm-novel-once-daily-bronchodilator-chronic-obstructive-pulmonary-disease 2022-07-07T10:27:39-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/plaintiff-sales-representatives-and-novartis-pharmaceuticals-corporation-resolve-class-action-wage-and-hour-claims 2022-07-07T10:27:39-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pivotal-study-exjade-shows-significant-reduction-iron-overload-patients-non-transfusion-dependent-thalassemia 2022-07-07T10:27:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/two-novartis-phase-iii-studies-show-twice-many-ph-cml-patients-achieve-deeper-levels-response-tasigna-compared-gleevec 2022-07-07T10:27:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-phase-iii-study-shows-acz885-helped-substantially-reduce-steroid-use-45-patients-serious-form-childhood-arthritis 2022-07-07T10:27:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-afinitor-helps-women-advanced-breast-cancer-live-significantly-longer-without-their-disease-progressing 2022-07-07T10:27:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-study-shows-qti571-significantly-improved-walking-distance-patients-life-threatening-pulmonary-arterial-hypertension 2022-07-07T10:27:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-afinitor-effective-patients-non-cancerous-kidney-tumors-associated-tsc-phase-iii-trial 2022-07-07T10:27:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-study-showed-acz885-provided-substantial-symptom-relief-84-patients-most-serious-form-childhood-arthritis 2022-07-07T10:27:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-supplemental-new-drug-application-novartis-therapy-gilenyatm-include-data-showing-reduction-t1-lesions-ms-marker-disease-activity 2022-07-07T10:27:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-arcaptatm-neohalertm-novel-once-daily-bronchodilator-chronic-obstructive-pulmonary-disease 2022-07-07T10:27:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-shows-acz885-severe-gouty-arthritis-provided-better-pain-relief-and-reduced-risk-new-attacks-68-vs-steroid 2022-07-07T10:27:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-phil-keoghan-host-amazing-race-raise-awareness-multiple-sclerosis-through-inspirational-national-bike-tour 2022-07-07T10:27:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-afinitor-first-new-treatment-nearly-three-decades-patients-advanced-pancreatic-net 2022-07-07T10:27:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-therapy-gilenyatm-reduced-risk-ms-disability-progression-regardless-treatment-history-or-disease-severity-new-analysis-shows 2022-07-07T10:27:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-advisory-committee-recommends-us-approval-novartis-once-daily-bronchodilator-qab149-copd 2022-07-07T10:27:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/important-information-extavia-interferon-beta-1-b-patients-regarding-triad-groups-alcohol-prep-products 2022-07-07T10:27:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-amturnidetm-triple-combination-pill-treat-high-blood-pressure-patients-uncontrolled-two-medications 2022-07-07T10:27:58-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/longer-term-phase-iii-data-show-novartis-drug-tasigna-continues-surpass-gleevec-slowing-disease-progression-patients-newly-diagnosed-cml 2022-07-07T10:27:58-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-restructuring-us-field-force-align-changing-product-portfolio-and-strategic-growth-priorities 2022-07-07T10:27:58-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-stand-together-ad-campaign-provides-strength-support-and-important-resources-11-million-alzheimers-caregivers 2022-07-07T10:28:01-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/analysis-shows-novartis-drug-tobi-associated-reduced-mortality-cystic-fibrosis-patients-common-lung-infection 2022-07-07T10:28:01-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-gilenyatm-novel-first-line-multiple-sclerosis-treatment-shown-significantly-reduce-relapses-and-delay-disability-progression 2022-07-07T10:28:01-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-tekamlotm-single-pill-combination-aliskiren-and-amlodipine-treat-high-blood-pressure 2022-07-07T10:28:04-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/us-affiliate-novartis-strongly-disputes-claims-past-discrimination-us 2022-07-07T10:28:04-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-prevails-medicaid-pricing-case-alabama-supreme-court 2022-07-07T10:28:04-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-tekturna-hct-initial-treatment-patients-unlikely-achieve-their-blood-pressure-goals-single-agent 2022-07-07T10:28:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-new-biological-therapy-ilaris-approved-us-treat-children-and-adults-caps-serious-life-long-auto-inflammatory-disease 2022-07-07T10:28:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-fda-approves-exforge-hct-only-high-blood-pressure-treatment-combine-three-medications-single-pill 2022-07-07T10:28:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-gleevec-receives-us-approval-first-treatment-reduce-risk-cancer-returning-patients-gastrointestinal-stromal-tumors 2022-07-07T10:28:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/rad001-shows-potential-reverse-resistance-herceptin-metastatic-breast-cancer-patients-leading-phase-iii-trial 2022-07-07T10:28:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-novartis-vaccines-and-pta-battle-flu-public-health-vaccination-initiative-urges-families-lets-fight-flu-together 2022-07-07T10:28:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/early-data-show-potential-imatinib-mesylate-tablets-treat-life-threatening-form-pulmonary-artery-disease 2022-07-07T10:28:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/rad001-combined-sandostatin-lar-depot-and-monotherapy-controls-growth-rare-pancreatic-neuroendocrine-tumors 2022-07-07T10:28:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/rad001-granted-priority-review-us-based-potential-fill-unmet-medical-need-patients-advanced-kidney-cancer 2022-07-07T10:28:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-appeal-judgment-alabama-pricing-case 2022-07-07T10:28:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-higher-initial-dose-gleevec-achieved-better-early-responses-standard-dose-patients-chronic-myeloid-leukemia 2022-07-07T10:28:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/early-data-presented-asco-show-potential-rad001-enhance-efficacy-and-overcome-resistance-breast-cancer-treatments 2022-07-20T16:05:08-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-major-independent-trial-demonstrates-significant-anticancer-benefit-zometa-women-early-stage-breast-cancer 2022-07-07T10:28:20-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/rad001-more-doubles-time-without-tumor-growth-after-failure-standard-treatment-patients-advanced-kidney-cancer 2022-07-07T10:28:20-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/strength-and-innovation-novartis-oncology-products-and-pipeline-potential-improve-patient-treatment-demonstrated-more-170-abstracts-asco-annual-meeting 2022-07-07T10:28:20-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-femara-helps-protect-against-return-breast-cancer-even-when-treatment-starts-several-years-after-completing-tamoxifen-therapy 2022-07-07T10:28:23-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/everolimus-rad001-significantly-extends-progression-free-survival-advanced-kidney-cancer-patients-after-failure-other-targeted-therapy 2022-07-07T10:28:23-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-and-photo-tekturna-hct-single-tablet-combination-tekturna-and-diuretic-receives-us-approval-treatment-high-blood-pressure 2022-07-07T10:28:23-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/photo-new-data-show-gleevec-halts-progression-advanced-stages-life-threatening-form-leukemia-sixth-year-treatment 2022-07-07T10:28:26-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/2005-release 2022-07-07T10:28:26-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/2004-release 2022-07-07T10:28:29-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-acquires-kedalion-therapeutics-and-its-innovative-ocular-delivery-platform-could-transform-patient-experience 2022-07-20T15:51:51-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-four-year-data-efficacy-and-safety-kesimpta-ofatumumab 2022-10-11T20:23:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-tafinlar-mekinist-approved-fda-pediatric-patients-braf-v600e-low-grade-glioma-most-common-pediatric-brain-cancer 2023-03-17T12:24:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ribociclib-kisqali-only-category-1-preferred-first-line-treatment-option-hrher2-mbc-combination-ai-updated-nccn-clinical-practice-guidelines-oncology-nccn-guidelines 2023-03-29T10:40:34-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-kymriah-car-t-cell-therapy-adult-patients-relapsed-or-refractory-follicular-lymphoma-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-vijoice-alpelisib-first-and-only-treatment-select-patients-pik3ca-related-overgrowth-spectrum-pros-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pluvictotm-approved-fda-first-targeted-radioligand-therapy-treatment-progressive-psma-positive-metastatic-castration-resistant-prostate-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-receives-fda-approval-treatment-children-and-adolescents-enthesitis-related-arthritis-and-psoriatic-arthritis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-leqvio-inclisiran-first-class-sirna-lower-cholesterol-and-keep-it-low-two-doses-year-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-t-chargetm-next-generation-car-t-platform-first-human-data-ash-2021-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kymriah-demonstrates-strong-responses-high-risk-patients-relapsed-or-refractory-follicular-lymphoma-extended-study-follow-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-highlight-efficacy-piqray-hrher2-metastatic-breast-cancer-pik3ca-driver-mutation-immediately-post-cdk46i-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-kisqali-data-shows-consistent-overall-survival-benefit-across-genomic-and-clinical-subtypes-interest-hrher2-metastatic-breast-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-iptacopan-meets-primary-endpoints-phase-ii-study-rare-kidney-disease-c3-glomerulopathy-c3g-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-scemblix-asciminib-novel-mechanism-action-treatment-chronic-myeloid-leukemia-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-kisqali-data-showing-longest-median-overall-survival-ever-reported-hrher2-advanced-breast-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-findings-from-real-world-study-alpelisib-demonstrating-clinical-benefit-people-pik3ca-related-overgrowth-spectrum-pros-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-meet-pros-raise-awareness-and-support-education-pik3ca-related-overgrowth-spectrum-pros-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pledges-10-year-commitment-morehouse-school-medicine-26-historically-black-colleges-universities-medical-schools-and-other-leading-organizations-co-create-effective-measurable-solutions-health-equity-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-checkpoint-inhibitor-tislelizumab-met-primary-endpoint-overall-survival-pivotal-phase-iii-trial-esophageal-cancer-after-systemic-therapy-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-tabrecta-first-published-overall-survival-and-updated-overall-response-data-patients-metex14-metastatic-nsclc-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-177lu-psma-617-significantly-improves-overall-survival-and-radiographic-progression-free-survival-men-metastatic-castration-resistant-prostate-cancer-phase-iii-vision-study-1 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kymriah-pivotal-trial-demonstrates-strong-response-rates-and-remarkable-safety-profile-relapsed-or-refractory-follicular-lymphoma-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-reports-longest-median-overall-survival-postmenopausal-hrher2-metastatic-breast-cancer-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-receives-fda-approval-treatment-children-and-adolescents-moderate-severe-plaque-psoriasis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-reports-one-year-results-phase-iii-merlin-study-evaluating-beovu-every-four-week-dosing-and-provides-update-beovu-clinical-program-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-commits-addressing-racial-disparities-breast-cancer-screening-treatment-and-care-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-phase-iii-beovu-data-show-potential-fluid-resolution-more-diabetic-macular-edema-patients-fewer-injections-versus-aflibercept-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-xolair-omalizumab-self-injection-prefilled-syringe-across-all-indications-appropriate-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-entresto-granted-expanded-indication-chronic-heart-failure-fda-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-positive-fda-advisory-committee-recommendation-use-entresto-treat-patients-hfpef-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-demonstrates-nearly-five-years-median-overall-survival-metastatic-breast-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-stamp-inhibitor-asciminib-abl001-shows-superior-mmr-rate-bosulif-chronic-myeloid-leukemia-trial-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-and-amgen-partner-karamo-brown-support-and-empower-people-living-migraine-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-adults-nasal-polyps-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-data-ash-reinforce-breadth-novartis-hematology-portfolio-across-multiple-blood-cancers-and-serious-hematologic-diseases-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-analyses-investigational-inclisiran-demonstrate-consistently-effective-and-sustained-ldl-c-reduction-month-17-regardless-age-and-gender-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-shows-early-synovitis-reduction-patients-psoriatic-arthritis-first-its-kind-study-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-five-year-data-reinforce-safety-and-efficacy-profile-aimovig-erenumab-aooe-adult-patients-episodic-migraine-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-us-foundation-commits-25m-improve-health-equity-reducing-health-disparities-us-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-data-actrims-ectrims-kesimpta-ofatumumab-newly-diagnosed-treatment-naive-adults-relapsing-multiple-sclerosis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-analysis-shows-high-consistency-lowering-ldl-c-individual-response-investigational-inclisiran-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-pso-know-podcast-series-hosted-music-icon-cyndi-lauper-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-kesimpta-ofatumumab-first-and-only-self-administered-targeted-b-cell-therapy-patients-relapsing-multiple-sclerosis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-xolair-omalizumab-prefilled-syringe-self-administration-across-all-indications-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-phase-iii-asclepios-trials-demonstrating-superior-efficacy-ofatumumab-patients-relapsing-multiple-sclerosis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-receives-fda-approval-new-indication-treat-active-non-radiographic-axial-spondyloarthritis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-long-term-relapse-free-survival-benefit-high-risk-stage-iii-melanoma-patients-treated-tafinlar-mekinist-following-surgery-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-late-breaking-ofatumumab-data-ean-underscoring-commitment-advancing-treatment-relapsing-forms-multiple-sclerosis-rms-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-shows-overall-survival-benefit-hrher2-advanced-breast-cancer-consistent-findings-patients-more-aggressive-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-met-inhibitor-tabrectatm-metastatic-non-small-cell-lung-cancer-metex14-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-us-foundation-supports-telehealth-programs-provide-access-care-new-jerseys-most-vulnerable-communities-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-analysis-further-showed-durable-and-potent-ldl-c-reduction-inclisiran-investigational-first-class-sirna-cholesterol-lowering-treatment-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-met-inhibitor-capmatinib-inc280-first-potential-treatment-metex14-mutated-advanced-non-small-cell-lung-cancer-granted-priority-fda-review-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/public-private-collaboration-commits-accelerate-access-health-services-africa-reaching-17-million-people-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-xolair-omalizumab-treatment-nasal-polyps-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kymriah-demonstrates-consistent-efficacy-and-safety-outcomes-us-patients-when-used-real-world-setting-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-medicine-adakveo-crizanlizumab-tmca-approved-fda-reduce-frequency-pain-crises-individuals-living-sickle-cell-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-pso-work-music-icon-cyndi-lauper-bring-life-impact-psoriasis-can-have-workplace-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-step-programtm-now-accepting-submissions-proposals-address-unmet-patient-needs-cancer-biomarker-testing-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-beovu-offering-wet-amd-patients-vision-gains-and-greater-fluid-reductions-vs-aflibercept-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-positive-52-week-prevent-data-confirm-cosentyx-efficacy-addressing-entire-axspa-spectrum-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-presents-new-data-epns-continuing-show-significant-therapeutic-benefit-zolgensma-prolonging-event-free-survival-now-5-years-age-patients-spinal-muscular-atrophy-sma-type-1-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/entresto-improved-measures-heart-structure-and-function-hfref-patients-new-novartis-study-additional-data-complement-findings-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-celebrity-interior-designer-nate-berkus-launch-my-home-sight-program-empowering-people-wet-amd-live-more-independently-home-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-accepts-file-and-accelerates-review-novartis-sickle-cell-disease-medicine-crizanlizumab-seg101-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-offers-free-genetic-mutation-testing-program-advanced-melanoma-patients-results-can-help-doctors-and-patients-making-cancer-treatment-decisions-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/long-term-survival-benefit-shown-metastatic-melanoma-patients-treated-novartis-tafinlar-mekinist-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-shows-growing-strength-lung-cancer-innovation-new-capmatinib-investigational-data-and-novel-canakinumab-clinical-trials-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-announces-innovative-zolgensma-gene-therapy-access-programs-us-payers-and-families-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-receives-fda-approval-zolgensma-first-and-only-gene-therapy-pediatric-patients-spinal-muscular-atrophy-sma-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-asco-and-eha-demonstrate-novel-approaches-reimagining-medicine-cancer-and-serious-blood-disorders-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/five-nonprofit-organizations-receive-250000-through-novartis-step-programtm-support-sickle-cell-patient-initiatives-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-issues-voluntary-nationwide-recall-promacta-125-mg-oral-suspension-due-potential-peanut-contamination-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-avexis-data-aan-showed-long-term-durability-zolgensma-patients-spinal-muscular-atrophy-sma-type-1-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-presented-robust-data-aan-demonstrating-efficacy-zolgensma-broad-spectrum-spinal-muscular-atrophy-sma-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-and-priority-review-brolucizumab-rth258-patients-wet-amd-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-expands-world-leading-gene-therapy-manufacturing-capacity-purchase-advanced-biologics-therapy-manufacturing-campus-longmont-colorado-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-mayzent-siponimod-first-oral-drug-treat-secondary-progressive-ms-active-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-late-breaking-data-further-support-initiation-entresto-hospital-and-first-choice-systolic-heart-failure-therapy-stabilized-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-show-psoriasis-patients-treated-cosentyx-reported-improvements-quality-life-measures-early-week-4-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-therapy-crizanlizumab-seg101-receives-fda-breakthrough-therapy-designation-prevention-vaso-occlusive-crises-sickle-cell-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-demonstrates-consistent-efficacy-and-tolerability-kisqali-combination-therapy-hrher2-advanced-breast-cancer-patients-difficult-treat-visceral-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-byl719-alpelisib-plus-fulvestrant-consistently-improved-pfs-patients-pik3ca-mutated-hrher2-advanced-breast-cancer-new-solar-1-analyses-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/real-world-data-show-novartis-drug-promacta-improves-outcomes-itp-patients-compared-other-second-line-therapies-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-longer-term-analyses-from-pivotal-kymriah-trials-showed-durable-responses-are-maintained-patients-advanced-blood-cancers-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-crizanlizumab-seg101-data-analysis-sickle-cell-disease-and-investment-sentry-clinical-program-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-drug-promacta-first-line-saa-and-grants-breakthrough-therapy-designation-additional-new-indication-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-fund-five-innovative-ideas-support-patients-and-sickle-cell-community-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-study-supports-entresto-foundational-hfref-therapy-and-hospital-initiation-appropriate-stabilized-heart-failure-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-ash-and-sabcs-show-strength-pipeline-and-portfolio-hematology-and-oncology-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-wins-esteemed-prix-galien-foundation-best-biotechnology-product-award-car-t-cell-therapy-kymriah-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/two-year-data-novartis-brolucizumab-reaffirm-superiority-versus-aflibercept-reducing-retinal-fluid-patients-namd-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-cosentyx-data-demonstrating-long-term-response-and-safety-ankylosing-spondylitis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-analysis-shows-crizanlizumab-seg101-increased-number-patients-free-sickle-cell-pain-crises-vs-placebo-during-sustain-study-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-siponimod-baf312-first-and-only-oral-drug-shown-delay-disability-progression-typical-spms-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-recording-artist-and-actress-jordin-sparks-and-scdaa-launch-generation-s-inspiring-new-sickle-cell-storytelling-project-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-landmark-paradigms-study-demonstrating-significant-benefit-gilenya-children-and-adolescents-relapsing-multiple-sclerosis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-now-first-and-only-cdk46-inhibitor-indicated-us-first-line-therapy-specifically-premenopausal-women-and-initial-therapy-fulvestrant-postmenopausal-women-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-galaxies-hope-app-digital-experience-neuroendocrine-tumor-net-cancer-community-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/sandoz-inc-and-its-affiliate-novartis-pharmaceuticals-corporation-voluntarily-recall-select-blister-packages-products-us-due-packaging-requirements-child-resistance-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-and-amgen-highlight-findings-from-large-global-patient-survey-revealing-worldwide-approximately-60-employed-people-migraine-missed-average-week-work-month-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-funding-patient-advocacy-initiatives-support-and-empower-metastatic-breast-cancer-community-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-inclusion-new-evidence-cosentyx-inhibits-progression-joint-structural-damage-psoriatic-arthritis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-juliet-trial-kymriah-demonstrates-more-one-year-durability-responses-adults-relapsed-or-refractory-dlbcl-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-survey-uncovers-real-world-impact-immune-thrombocytopenia-or-itp-rare-blood-disease-patients-quality-life-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/third-novartis-phase-iii-trial-shows-kisqali-combination-therapy-significantly-improves-pfs-hrher2-advanced-breast-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-expedites-review-novartis-drug-promacta-first-line-severe-aplastic-anemia-saa-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/patient-reported-outcomes-tool-revealed-significant-improvement-symptom-frequency-and-quality-life-domains-entresto-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-and-amgen-announce-fda-approval-aimovigtm-erenumab-aooe-novel-treatment-developed-specifically-migraine-prevention-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-asco-and-eha-reinforce-companys-commitment-reimagining-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-teams-venus-williams-tennis-champion-and-dry-eye-sufferer-launch-systane-complete-eye-drops-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-gilenya-first-disease-modifying-therapy-pediatric-relapsing-multiple-sclerosis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/kymriah-tisagenlecleucel-first-class-car-t-therapy-from-novartis-receives-second-fda-approval-treat-appropriate-rr-patients-large-b-cell-lymphoma-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-introduces-air-optix-colors-contact-lenses-gemstone-collection-creating-new-ways-enhance-and-play-eye-color-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-phase-iii-data-brolucizumab-demonstrate-reliability-12-week-treatment-interval-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-focalview-app-providing-opportunity-patients-participate-ophthalmology-clinical-trials-from-home-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/phase-iii-data-lancet-show-novartis-siponimod-significantly-improved-outcomes-patients-secondary-progressive-ms-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-data-show-cosentyx-improved-quality-life-over-5-years-two-thirds-patients-moderate-severe-plaque-psoriasis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-cosentyx-label-update-include-moderate-severe-scalp-psoriasis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-data-reinforces-superiority-cosentyx-versus-stelara-achieving-skin-clearance-psoriasis-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-promacta-receives-fda-breakthrough-therapy-designation-first-line-use-severe-aplastic-anemia-saa-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-received-fda-breakthrough-therapy-designation-initial-endocrine-based-treatment-premenopausal-women-hrher2-advanced-breast-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-multiple-sclerosis-therapy-fingolimod-granted-fda-breakthrough-therapy-designation-pediatric-ms-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-crizanlizumab-shown-prolong-time-patients-first-sickle-cell-pain-crisis-subgroup-analysis-sustain-study-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/primary-analysis-results-from-novartis-pivotal-juliet-trial-show-kymriahtm-tisagenlecleucel-sustained-complete-responses-six-months-adults-rr-dlbcl-difficult-treat-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-initiates-study-evaluating-impact-higher-dosing-cosentyx-patients-ankylosing-spondylitis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-first-and-only-cdk46-inhibitor-show-superior-median-pfs-compared-oral-endocrine-therapy-first-line-treatment-prospective-randomized-phase-iii-trial-dedicated-premenopausal-women-hrher2-advanced-breast-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-data-sabcs-across-broad-range-breast-cancer-patient-populations-combination-treatments-and-lines-therapy-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-canakinumab-acz885-reduced-cardiovascular-risk-25-subgroup-cantos-phase-iii-trial-participants-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-brolucizumab-rth258-demonstrates-superiority-versus-aflibercept-key-secondary-endpoint-measures-disease-activity-namd-leading-cause-blindness-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-study-data-demonstrating-cosentyx-reduced-signs-and-symptoms-psoriatic-arthritis-while-inhibiting-progression-joint-structural-damage-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-data-ash-patients-serious-blood-disorders-lymphoma-leukemia-and-sickle-cell-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pivotal-data-show-children-and-adolescents-relapsing-ms-had-82-lower-relapse-rate-fingolimod-vs-interferon-beta-1a-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-collaborates-pop-icon-cyndi-lauper-release-new-song-honor-world-psoriasis-day-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-promacta-shows-long-term-disease-control-chronicpersistent-immune-thrombocytopenia-itp-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-dailies-teams-us-olympians-world-class-gymnast-laurie-hernandez-and-soccer-star-tobin-heath-launch-invisible-edge-campaign-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-actress-producer-and-activist-eva-longoria-launch-kiss-4-mbctm-generate-research-funding-and-support-metastatic-breast-cancer-community-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-sets-new-benchmark-psoriasis-robust-5-year-sustained-efficacy-and-safety-phase-iii-data-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/multimedia-assets-now-available-novartis-receives-first-ever-fda-approval-car-t-cell-therapy-kymriahtm-tisagenlecleucel-ctl019-children-and-young-adults-b-cell-all-refractory-or-has-relapsed-least-twice-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-first-ever-fda-approval-car-t-cell-therapy-kymriahtm-tisagenlecleucel-ctl019-children-and-young-adults-b-cell-all-refractory-or-has-relapsed-least-twice-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-first-large-scale-research-study-multiple-sclerosis-allows-participants-contribute-from-smartphones-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-accepts-biologics-license-application-amg-334-erenumab-important-regulatory-milestone-novartis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-confirms-5-year-data-first-and-only-fully-human-il-17a-inhibitor-cosentyx-reinforcing-sustained-efficacy-and-safety-profile-psoriasis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pivotal-ctl019-6-month-follow-data-show-durable-remission-rates-children-young-adults-rr-b-cell-all-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-interim-results-from-global-pivotal-ctl019-trial-show-durable-complete-responses-adults-rr-dlbcl-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-first-its-kind-kisqali-femara-co-pack-initial-treatment-hrher2-advanced-or-metastatic-breast-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-expands-global-collaboration-amgen-commercialize-first-class-amg-334-erenumab-program-migraine-prevention-us-and-canada-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-car-t-cell-therapy-ctl019-receives-fda-breakthrough-therapy-designation-treatment-adult-patients-rr-dlbcl-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-first-car-t-cell-therapy-bla-pediatric-and-young-adult-patients-rr-b-cell-all-granted-fda-priority-review-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-analysis-shows-novartis-entresto-improves-glycemic-control-reduced-ejection-fraction-heart-failure-patients-diabetes-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-shows-almost-all-psoriasis-patients-rapidly-regain-skin-clearance-following-treatment-pause-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-receives-us-fda-approval-acrysof-iq-restor-30d-multifocal-toric-intraocular-lens-cataract-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-out-licenses-three-copd-products-us-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-results-from-first-global-registration-trial-ctl019-pediatric-and-young-adult-patients-rr-b-all-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-analysis-novartis-entresto-data-shows-long-term-benefits-heart-failure-readmissions-and-total-cardiovascular-deaths-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-introduces-new-air-optix-plus-hydraglyde-monthly-replacement-contact-lenses-american-academy-optometry-annual-meeting-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-partners-prominent-us-health-advocacy-organizations-launch-first-social-networking-platform-heart-failure-patients-and-their-loved-ones-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-late-breaking-data-show-cosentyx-continues-deliver-high-skin-clearance-majority-psoriasis-patients-four-years-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-three-new-fda-approvals-expanded-use-ilaris-patients-rare-periodic-fever-syndrome-conditions-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/important-new-analysis-shows-novartis-entresto-associated-higher-relative-health-related-quality-life-scores-among-hfref-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-baf312-reduced-risk-disability-progression-pivotal-phase-iii-study-secondary-progressive-ms-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-finds-relapsing-ms-patients-gilenya-had-greater-treatment-retention-and-satisfaction-rates-vs-injectable-dmts-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-pediatric-allergic-asthma-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/largest-global-psoriasis-survey-shows-85-us-respondents-faced-social-stigma-discrimination-and-humiliation-because-their-skin-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/timely-use-novartis-entresto-could-prevent-or-postpone-over-28000-us-deaths-year-among-hfref-patients-according-expert-analysis-jama-cardiology-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-show-gilenya-had-significantly-greater-patient-retention-compared-idmts-relapsing-remitting-ms-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/media-statement-leading-us-cardiology-societies-strongly-recommend-entresto-new-standard-care-treatment-earlier-expected-joint-update-clinical-practice-guidelines-heart-failure-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/media-statement-fortihfy-global-clinical-program-entresto-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-three-fda-breakthrough-therapy-designations-ilaris-treat-rare-types-periodic-fever-syndromes-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-analyses-show-novartis-entrestotm-reduced-cardiovascular-death-or-hospitalization-heart-failure-consistently-benefitting-patients-reduced-ejection-fraction-hfref-regardless-prior-heart-failure-hospital-admissions-or-background-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-data-show-cosentyx-demonstrated-sustained-superiority-skin-clearance-pasi-90-versus-stelara-week-52-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-new-indication-novartis-drug-afinitor-progressive-nonfunctional-gi-and-lung-neuroendocrine-tumors-net-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-two-new-fda-approvals-cosentyx-secukinumab-treat-patients-ankylosing-spondylitis-and-psoriatic-arthritis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-publication-two-landmark-studies-nejm-demonstrating-efficacy-cosentyx-patients-ankylosing-spondylitis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-new-ctl019-phase-ii-data-demonstrating-93-complete-remission-pediatric-patients-rr-all-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-ctl019-study-data-demonstrating-overall-response-adult-patients-certain-types-lymphoma-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-finalizes-settlement-agreement-resolving-civil-suit-filed-us-attorneys-office-southern-district-new-york-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-heart-failure-medicine-entrestotm-substantially-cuts-30-day-hospital-readmissions-new-post-hoc-analysis-shows-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/80-ankylosing-spondylitis-patients-treated-cosentyx-show-no-spinal-x-ray-progression-shown-novartis-new-two-year-observational-data-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/approximately-80-psoriatic-arthritis-patients-treated-cosentyx-saw-no-progression-joint-damage-shown-novartis-new-two-year-observational-data-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-new-novartis-dual-combination-bronchodilator-utibrontm-neohaler-patients-chronic-obstructive-pulmonary-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-clarification-specialty-pharmacy-settlement-principle-announcement-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-secukinumab-phase-iii-data-confirming-significant-efficacy-patients-psoriatic-arthritis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/patients-aggressive-form-melanoma-lived-more-two-years-average-when-taking-novartis-therapies-tafinlar-mekinist-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-novartis-access-portfolio-affordable-medicines-treat-chronic-diseases-lower-income-countries-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-drug-odomzo-sonidegib-locally-advanced-basal-cell-carcinoma-labcc-form-skin-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-heart-failure-medicine-lcz696-approved-fda-reduce-risk-cardiovascular-death-and-heart-failure-hospitalization-now-called-entrestotm-sacubitrilvalsartan-0 2025-02-13T11:41:27-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-data-wcd-shows-significant-efficacy-cosentyx-patients-psoriasis-palms-soles-feet-and-nails-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-ctl019-data-showing-its-potential-treatment-specific-types-hard-treat-non-hodgkin-lymphoma-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/combination-novartis-drugs-tafinlar-and-mekinist-shows-significant-survival-benefit-patients-metastatic-melanoma-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-dual-bronchodilator-significantly-improved-lung-function-compared-single-bronchodilators-patients-moderate-severe-copd-phase-iii-studies-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-jadenutm-simplify-treatment-administration-patients-chronic-iron-overload-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-cosentyxtm-two-year-efficacy-and-safety-data-showing-sustainable-effect-psoriasis-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-data-show-more-cosentyxtm-treated-psoriasis-patients-achieved-clear-or-almost-clear-skin-pasi-90-compared-stelara-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-heart-failure-medicine-lcz696-granted-fda-priority-review-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-first-il-17a-antagonist-cosentyxtm-secukinumab-moderate-severe-plaque-psoriasis-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-signifor-lar-treat-patients-acromegaly-rare-and-life-threatening-hormonal-disorder-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-signifor-lar-treat-patients-acromegaly-rare-and-life-threatening-hormonal-disorder-1 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-new-ctl019-clinical-data-showing-complete-remissions-children-and-young-adults-relapsedrefractory-acute-lymphoblastic-leukemia-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/nine-new-analyses-show-novartis-lcz696-could-change-course-heart-failure-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-first-il-17a-phase-iii-results-show-ain457-secukinumab-significantly-improves-psoriatic-arthritis-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ain457-secukinumab-showed-significant-symptom-improvement-two-pivotal-phase-iii-ankylosing-spondylitis-studies-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-present-first-il-17a-phase-iii-data-ain457-secukinumab-psoriatic-arthritis-and-ankylosing-spondylitis-acr-2014-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-multiple-sclerosis-advocate-and-musician-david-osmond-launch-ms-education-initiative-our-voice-songtm-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-advisory-committee-unanimously-recommends-approval-ain457-secukinumab-patients-moderate-severe-plaque-psoriasis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-ctl019-data-published-nejm-demonstrating-efficacy-certain-patients-acute-lymphoblastic-leukemia-all-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-afinitor-first-treatment-advanced-pancreatic-net-provide-overall-survival-more-35-years-phase-iii-trial-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-heart-failure-medicine-lcz696-cut-cardiovascular-deaths-20-vs-ace-inhibitor-landmark-paradigm-hf-trial-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-showcase-heart-failure-leadership-esc-congress-2014-results-new-first-its-type-medicine-lcz696-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-two-pivotal-phase-iii-secukinumab-studies-demonstrating-statistically-significant-skin-clearance-psoriasis-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-personalized-cell-therapy-ctl019-receives-fda-breakthrough-therapy-designation-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/pivotal-data-novartis-investigational-compound-lde225-show-marked-tumor-responses-advanced-basal-cell-carcinoma-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-key-advances-cancer-research-asco-and-eha-from-four-new-pivotal-studies-lung-blood-and-skin-cancers-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-signifor-lar-shows-superior-efficacy-acromegaly-patients-not-controlled-first-generation-somatostatin-analogues-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-reports-new-phase-iii-data-showing-secukinumab-ain457-improved-moderate-severe-plaque-psoriasis-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-chronic-idiopathic-urticaria-ciu-form-chronic-hives-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-stands-behind-medication-adherence-activities-and-reaffirms-commitment-patient-safety-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-research-investigational-personalized-t-cell-therapy-ctl019-patients-forms-acute-and-chronic-leukemia-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-hosts-competition-create-novel-mobile-solutions-heart-failure-caregivers-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-data-effects-investigational-rlx030-kidney-blood-flow-chronic-heart-failure-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-exelon-patch-now-fda-approved-treat-patients-across-all-stages-alzheimers-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/tv-host-phil-keoghan-and-novartis-team-inspire-people-ms-through-innovative-tandem-cycling-campaign-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/relapsing-ms-patients-more-satisfied-novartis-oral-drug-gilenya-standard-injectable-therapies-according-new-study-results-cmsc-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-new-findings-advancing-care-patients-170-abstracts-breast-lung-and-blood-cancers-asco-and-eha-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-disputes-allegations-two-us-government-lawsuits-and-looks-forward-fair-discussion-facts-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-tobi-podhalertm-certain-cystic-fibrosis-patients-first-and-only-dry-powder-inhaled-antibacterial-us-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-analysis-shows-novartis-drug-gilenya-significantly-reduced-rate-brain-volume-loss-across-three-large-phase-iii-studies-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-reports-omalizumab-significantly-improved-chronic-idiopathic-urticaria-symptoms-patients-who-failed-standard-therapy-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-zortress-first-over-decade-approved-fda-prevent-organ-rejection-adult-liver-transplant-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-exjade-first-treatment-approved-fda-chronic-iron-overload-patients-non-transfusion-dependent-thalassemia-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/nejm-published-study-shows-novartis-compound-acz885-significantly-relieves-symptoms-patients-serious-form-childhood-arthritis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/multimedia-assets-novartis-drug-signifor-gains-fda-approval-first-medication-treat-cushings-disease-serious-endocrine-disorder-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-signifor-gains-fda-approval-first-medication-treat-cushings-disease-serious-endocrine-disorder-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-phase-iii-study-shows-rlx030-improved-symptoms-and-reduced-deaths-one-third-patients-acute-heart-failure-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/leeza-gibbons-joins-novartis-improve-caregiving-experience-millions-americans-through-real-world-peer-advice-alzheimersdiseasecom-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-emprende-una-campana-de-educacion-de-la-comunidad-hispana-de-ee-uu-sobre-la-enfermedad-de-alzheimer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-embarks-alzheimers-disease-educational-effort-us-hispanic-community-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-advisory-committee-supports-use-tobramycin-inhalation-powder-from-novartis-patients-cystic-fibrosis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/higher-dose-novartis-drug-exelon-patch-approved-fda-patients-mild-moderate-alzheimers-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/npc-statement-comments-made-media-coverage-paycheck-fairness-act-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/two-new-analyses-reinforce-consistent-efficacy-novartis-therapy-gilenya-across-wide-range-relapsing-ms-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/tv-host-phil-keoghan-and-professional-women-cyclists-join-novartis-raise-awareness-multiple-sclerosis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/higher-dose-novartis-drug-exelon-patch-showed-statistically-significantly-less-decline-function-alzheimers-vs-lower-dose-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-extension-study-data-novartis-drug-gilenya-shows-patients-successfully-treated-7-years-relapsing-ms-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-update-united-states-prescribing-information-ms-therapy-gilenya-following-fda-review-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-expands-transplant-portfolio-hecoria-first-generic-tacrolimus-can-be-prescribed-brand-name-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-arcaptatm-neohalertm-novel-once-daily-bronchodilator-chronic-obstructive-pulmonary-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/plaintiff-sales-representatives-and-novartis-pharmaceuticals-corporation-resolve-class-action-wage-and-hour-claims-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pivotal-study-exjade-shows-significant-reduction-iron-overload-patients-non-transfusion-dependent-thalassemia-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/two-novartis-phase-iii-studies-show-twice-many-ph-cml-patients-achieve-deeper-levels-response-tasigna-compared-gleevec-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-phase-iii-study-shows-acz885-helped-substantially-reduce-steroid-use-45-patients-serious-form-childhood-arthritis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-afinitor-helps-women-advanced-breast-cancer-live-significantly-longer-without-their-disease-progressing-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-study-shows-qti571-significantly-improved-walking-distance-patients-life-threatening-pulmonary-arterial-hypertension-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-afinitor-effective-patients-non-cancerous-kidney-tumors-associated-tsc-phase-iii-trial-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-study-showed-acz885-provided-substantial-symptom-relief-84-patients-most-serious-form-childhood-arthritis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-supplemental-new-drug-application-novartis-therapy-gilenyatm-include-data-showing-reduction-t1-lesions-ms-marker-disease-activity-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-arcaptatm-neohalertm-novel-once-daily-bronchodilator-chronic-obstructive-pulmonary-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-shows-acz885-severe-gouty-arthritis-provided-better-pain-relief-and-reduced-risk-new-attacks-68-vs-steroid-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-phil-keoghan-host-amazing-race-raise-awareness-multiple-sclerosis-through-inspirational-national-bike-tour-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-afinitor-first-new-treatment-nearly-three-decades-patients-advanced-pancreatic-net-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-therapy-gilenyatm-reduced-risk-ms-disability-progression-regardless-treatment-history-or-disease-severity-new-analysis-shows-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-advisory-committee-recommends-us-approval-novartis-once-daily-bronchodilator-qab149-copd-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/important-information-extavia-interferon-beta-1-b-patients-regarding-triad-groups-alcohol-prep-products-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-amturnidetm-triple-combination-pill-treat-high-blood-pressure-patients-uncontrolled-two-medications-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/longer-term-phase-iii-data-show-novartis-drug-tasigna-continues-surpass-gleevec-slowing-disease-progression-patients-newly-diagnosed-cml-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-restructuring-us-field-force-align-changing-product-portfolio-and-strategic-growth-priorities-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-stand-together-ad-campaign-provides-strength-support-and-important-resources-11-million-alzheimers-caregivers-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/analysis-shows-novartis-drug-tobi-associated-reduced-mortality-cystic-fibrosis-patients-common-lung-infection-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-gilenyatm-novel-first-line-multiple-sclerosis-treatment-shown-significantly-reduce-relapses-and-delay-disability-progression-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-tekamlotm-single-pill-combination-aliskiren-and-amlodipine-treat-high-blood-pressure-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/us-affiliate-novartis-strongly-disputes-claims-past-discrimination-us-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-prevails-medicaid-pricing-case-alabama-supreme-court-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-tekturna-hct-initial-treatment-patients-unlikely-achieve-their-blood-pressure-goals-single-agent-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-new-biological-therapy-ilaris-approved-us-treat-children-and-adults-caps-serious-life-long-auto-inflammatory-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-fda-approves-exforge-hct-only-high-blood-pressure-treatment-combine-three-medications-single-pill-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-gleevec-receives-us-approval-first-treatment-reduce-risk-cancer-returning-patients-gastrointestinal-stromal-tumors-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/rad001-shows-potential-reverse-resistance-herceptin-metastatic-breast-cancer-patients-leading-phase-iii-trial-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-novartis-vaccines-and-pta-battle-flu-public-health-vaccination-initiative-urges-families-lets-fight-flu-together-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/early-data-show-potential-imatinib-mesylate-tablets-treat-life-threatening-form-pulmonary-artery-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/rad001-combined-sandostatin-lar-depot-and-monotherapy-controls-growth-rare-pancreatic-neuroendocrine-tumors-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/rad001-granted-priority-review-us-based-potential-fill-unmet-medical-need-patients-advanced-kidney-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-appeal-judgment-alabama-pricing-case-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-higher-initial-dose-gleevec-achieved-better-early-responses-standard-dose-patients-chronic-myeloid-leukemia-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/early-data-presented-asco-show-potential-rad001-enhance-efficacy-and-overcome-resistance-breast-cancer-treatments-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-major-independent-trial-demonstrates-significant-anticancer-benefit-zometa-women-early-stage-breast-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/rad001-more-doubles-time-without-tumor-growth-after-failure-standard-treatment-patients-advanced-kidney-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/strength-and-innovation-novartis-oncology-products-and-pipeline-potential-improve-patient-treatment-demonstrated-more-170-abstracts-asco-annual-meeting-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-femara-helps-protect-against-return-breast-cancer-even-when-treatment-starts-several-years-after-completing-tamoxifen-therapy-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/everolimus-rad001-significantly-extends-progression-free-survival-advanced-kidney-cancer-patients-after-failure-other-targeted-therapy-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-and-photo-tekturna-hct-single-tablet-combination-tekturna-and-diuretic-receives-us-approval-treatment-high-blood-pressure-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/photo-new-data-show-gleevec-halts-progression-advanced-stages-life-threatening-form-leukemia-sixth-year-treatment-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/2005-release-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/2004-release-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-significantly-reduced-risk-recurrence-25-across-broad-population-patients-early-breast-cancer-clinically-meaningful-benefit-was-consistent-across-subgroups 2024-03-04T06:49:58-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-five-year-data-disability-outcomes-and-safety-kesimpta-ofatumumab-people-living-relapsing-multiple-sclerosis 2023-12-28T13:50:04-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-phase-iii-natalee-trial-meets-primary-endpoint-interim-analysis-demonstrating-clinically-meaningful-benefit-broad-population-patients-early-breast-cancer 2024-04-30T06:50:06-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-pivotal-phase-iii-apply-pnh-data-ash-demonstrating-investigational-oral-monotherapy-iptacopan-superiority-over-anti-c5 2024-01-25T07:04:35-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-iptacopan-provides-clinically-meaningful-increases-hemoglobin-levels-complement-inhibitor-naive-patients-pnh 2024-02-11T06:49:41-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-prolonged-pfs-benefit-pre-and-perimenopausal-patients-aggressive-hrher2-metastatic-breast-cancer-compared-chemotherapy 2023-12-28T13:50:04-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-scientific-advances-kisqali-iptacopan-scemblix-and-ytb323-data-sabcs-and-ash 2023-12-28T13:50:04-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-expands-beacon-hope-through-alliances-historically-black-medical-schools-address-systemic-health-disparities 2023-12-14T06:50:05-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-scemblix-novel-mechanism-action-shows-superior-long-term-efficacy-and-consistent-tolerability-96-week-follow-chronic-myeloid-leukemia-trial 2023-12-28T13:50:04-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-premieres-powerful-new-docuseries-tribeca-festival-shine-light-debilitating-skin-disease 2024-04-14T06:49:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/us-fda-approves-expanded-indication-novartis-leqvio-inclisiran-include-treatment-adults-high-ldl-c-and-who-are-increased-risk-heart-disease 2024-04-16T09:49:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-strengthens-commitment-beacon-hope-initiative-engages-new-collaborators-support-clinical-trial-diversity-break-down-economic-and-education-barriers 2025-02-08T22:41:48-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-long-term-leqvio-inclisiran-data-demonstrating-consistent-efficacy-and-safety-beyond-six-years 2024-03-27T06:50:24-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-issues-voluntary-nationwide-recall-one-lot-sandimmune-oral-solution-cyclosporine-oral-solution-usp-100-mgml-due-crystallization 2023-12-28T13:35:07-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-cosentyx-first-intravenous-iv-formulation-interleukin-17a-antagonist-rheumatic-diseases 2023-12-28T13:50:04-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pluvicto-shows-clinically-meaningful-and-highly-statistically-significant-rpfs-benefit-patients-psma-positive-metastatic-castration-resistant-prostate-cancer-pre-taxane-setting 2024-01-08T05:50:07-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-confirms-unconstrained-supply-pluvicto-and-continues-significantly-expand-number-treatment-centers 2023-10-26T17:47:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-cosentyx-first-new-biologic-treatment-option-hidradenitis-suppurativa-patients-nearly-decade 2023-12-28T13:50:04-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-issues-voluntary-us-nationwide-recall-two-lots-sandimmune-oral-solution-cyclosporine-oral-solution-usp-100-mgml-due-crystallization 2023-12-04T06:36:01-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-fabhalta-iptacopan-offering-superior-hemoglobin-improvement-absence-transfusions-first-oral-monotherapy-adults-pnh 2023-12-06T00:35:53-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/latest-novartis-kisqali-natalee-analysis-reinforces-25-reduction-risk-recurrence-across-broad-population-patients-early-breast-cancer-supports-regulatory-submissions 2024-03-27T06:50:24-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-48-week-results-from-phase-iii-apply-pnh-trial-showing-sustained-efficacy-and-long-term-safety-fabhalta-iptacopan-adults-paroxysmal-nocturnal-hemoglobinuria-pnh 2023-12-10T20:05:58-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-expands-production-pluvicto-addition-its-largest-and-most-advanced-radioligand-therapy-manufacturing-facility-indianapolis 2024-01-05T09:50:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-lutathera-significantly-reduced-risk-disease-progression-or-death-72-first-line-treatment-patients-advanced-gastroenteropancreatic-neuroendocrine-tumors 2024-01-19T10:19:32-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-xolair-omalizumab-first-and-only-medicine-children-and-adults-one-or-more-food-allergies 2024-02-16T11:34:40-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-england-journal-medicine-publishes-phase-iii-data-showing-xolair-omalizumab-significantly-reduced-allergic-reactions-across-multiple-foods-people-food-allergies 2024-02-25T14:04:54-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-plans-expand-its-us-based-manufacturing-and-rd-footprint-total-investment-23b-over-next-5-years 2025-10-23T03:37:47-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-opens-new-radioligand-therapy-manufacturing-facility-california-part-23b-us-expansion-plan 2025-11-10T10:28:31-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-plans-build-flagship-manufacturing-hub-north-carolina 2025-11-19T12:35:44-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-breaks-ground-flagship-manufacturing-hub-north-carolina 2025-12-15T03:31:37-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-and-us-government-reach-agreement-lowering-drug-prices-us 2025-12-19T14:35:39-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-add-radioligand-therapy-manufacturing-facility-winter-park-florida-fourth-us-serve-patients-and-advance-23-billion-investment 2026-01-09T10:32:25-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-breaks-ground-new-global-biomedical-research-center-san-diego-accelerate-drug-discovery 2026-02-06T12:03:31-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-build-new-radioligand-therapy-site-denton-texas-delivering-more-next-generation-treatments-patients 2026-02-25T07:05:41-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-expansion-community-health-programs-close-gaps-heart-disease-and-cancer-care-targeting-more-30-countries-2030 2026-04-09T01:20:27-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-malaria-treatment-coartem-baby-receives-who-prequalification-paving-way-greater-access-newborns-and-young-infants 2026-04-24T01:20:37-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-finalizes-us-manufacturing-and-rd-expansion-plan-seventh-new-facility 2026-04-30T07:03:44-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-breaks-ground-denton-texas-radioligand-therapy-site-construction-now-underway-across-all-new-us-facilities 2026-05-07T09:02:42-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-delpacibart-braxlosiran-del-brax-phase-iii-study-facioscapulohumeral-muscular-dystrophy-fshd-meets-primary-biomarker-endpoint 2026-06-12T11:16:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-provides-update-delpacibart-etedesiran-del-desiran-phase-iii-harbor-study-treatment-myotonic-dystrophy-type-1-dm1 2026-09-11T08:35:47-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-lpahorizon-phase-iii-topline-results-pelacarsen-patients-elevated-lpa-and-established-cardiovascular-disease-cvd 2026-09-11T08:35:47-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-remibrutinib-high-efficacy-oral-btk-inhibitor-significantly-reduces-relapse-rates-and-shows-favorable-safety-profile-phase-iii-rms-trials 2026-09-11T08:35:47-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-esc-congress-2026-reinforce-cardiovascular-leadership-and-showcase-progress-next-generation-therapies 2026-09-11T08:35:47-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-pluvicto-psma-metastatic-hormone-sensitive-prostate-cancer-mhspc-advancing-potential-new-standard-care-across-metastatic-disease 2026-09-11T08:35:47-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-fabhalta-iptacopan-receives-fda-traditional-approval-first-and-only-complement-inhibitor-significantly-slow-kidney-function-decline-primary-igan 2026-09-11T18:50:51-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-remind-data-eaaci-show-rhapsido-potential-first-targeted-therapy-chronic-inducible-urticaria-cindu 2026-09-11T18:50:51-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlight-rhapsido-data-across-multiple-immune-mediated-diseases-eaaci-congress-2026 2026-09-11T18:50:51-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-igan-data-lancet-show-clinically-meaningful-slowing-kidney-function-decline-vanrafia-over-25-years 2026-09-11T18:50:51-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-pmr-data-new-england-journal-medicine-showed-sustained-remission-vs-placebo-twice-many-patients 2026-09-12T10:06:29-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/scemblix-continued-show-superior-efficacy-and-favorable-safety-and-tolerability-profile-week-144-newly-diagnosed-cml 2026-09-12T10:06:29-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-eular-2026-demonstrates-momentum-broad-immunology-portfolio-complex-high-unmet-need-diseases 2026-09-12T10:06:29-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/pluvicto-demonstrated-consistent-efficacy-across-key-patient-subgroups-metastatic-hormone-sensitive-prostate-cancer 2026-09-12T10:06:29-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-data-era-2026-advance-scientific-understanding-kidney-disease-and-reinforce-portfolio-strength 2026-09-12T10:06:29-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-advances-rlt-innovation-and-reinforces-leadership-prostate-cancer-breast-cancer-and-hematology-new-data-asco-and-eha 2026-09-12T10:06:29-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-psmaddition-data-show-58-lower-risk-psa-progression-pluvictotm-metastatic-hormone-sensitive-prostate-cancer 2026-09-12T10:06:29-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-igan-data-new-england-journal-medicine-show-fabhalta-slowed-kidney-function-decline-493 2026-09-12T10:06:29-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-data-early-symptom-relief-and-long-term-control-complex-skin-diseases-aad-2026 2026-09-12T10:06:29-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-receives-fda-approval-pediatric-patients-aged-12-moderate-severe-hidradenitis-suppurativa 2026-09-12T10:06:29-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-real-world-data-reinforce-earlier-use-pluvicto-chemotherapy-metastatic-castration-resistant-prostate-cancer 2026-09-12T10:06:29-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-rhapsido-remibrutinib-data-aaaai-showing-potential-beyond-chronic-spontaneous-urticaria-csu 2026-09-12T01:21:11-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-remibrutinib-first-therapy-achieve-phase-iii-primary-endpoint-chronic-inducible-urticaria-cindu 2026-09-12T01:21:11-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-vanrafia-phase-iii-data-support-slowing-kidney-function-decline-patients-iga-nephropathy 2026-09-12T01:21:11-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/nfl-greats-and-novartis-tackle-prostate-cancer-myths-super-bowl-lx-relax-its-blood-test 2026-09-12T01:21:11-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ianalumab-receives-fda-breakthrough-therapy-designation-sjogrens-disease 2026-09-12T01:21:11-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ianalumab-significantly-extends-disease-control-patients-immune-thrombocytopenia-only-four-once-monthly-doses 2026-09-12T01:21:11-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/1-4-metastatic-breast-cancer-patients-treated-novartis-kisqali-remain-progression-free-beyond-4-years 2026-09-12T01:21:11-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-underscore-pioneering-scientific-innovation-hematology-and-oncology-ash-and-sabcs 2026-09-12T04:51:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-itvisma-only-gene-replacement-therapy-children-two-years-and-older-teens-and-adults-spinal-muscular-atrophy-sma 2026-09-12T04:51:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-data-asn-kidney-week-and-aha-scientific-sessions-demonstrate-momentum-broad-crm-portfolio-and-pipeline 2026-09-12T04:51:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ianalumab-first-drug-reduce-disease-activity-and-patient-burden-sjogrens-disease-phase-iii-trials 2026-09-12T04:51:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-showcases-significant-immunology-advancements-acr-congress-new-data-complex-autoimmune-diseases 2026-09-12T04:51:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-meets-primary-and-all-secondary-endpoints-phase-iii-trial-patients-polymyalgia-rheumatica-pmr 2026-09-11T23:35:53-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/psmaddition-data-show-novartis-pluvictotm-delays-progression-end-stage-prostate-cancer 2026-09-11T23:35:53-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-5-year-natalee-data-demonstrate-28-reduction-risk-recurrence-broadest-early-breast-cancer-patient-population 2026-09-11T23:35:53-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-fabhalta-iptacopan-meets-phase-iii-primary-endpoint-slows-kidney-function-decline-patients-iga-nephropathy-igan 2026-09-12T13:20:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-rhapsido-remibrutinib-only-oral-targeted-btki-treatment-chronic-spontaneous-urticaria-csu 2026-09-12T13:20:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launch-direct-patient-platform-cosentyx-secukinumab-us 2026-09-12T13:20:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-data-further-support-benefits-kesimpta-relapsing-ms-following-switch-from-oral-disease-modifying-therapies 2026-09-12T13:20:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ianalumab-phase-iii-trial-meets-primary-endpoint-itp-demonstrating-statistically-significant-improvement-time-treatment-failure 2026-09-12T13:20:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-both-ianalumab-phase-iii-clinical-trials-met-primary-endpoint-patients-sjogrens-disease 2026-09-12T13:20:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-twice-yearly-leqvio-inclisiran-receives-fda-approval-new-indication-enabling-first-line-use 2026-09-12T13:20:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-provides-update-phase-iii-gcaptain-study-cosentyx-giant-cell-arteritis-gca 2026-09-12T13:20:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pluvictotm-demonstrates-statistically-significant-and-clinically-meaningful-rpfs-benefit-patients-psma-positive-metastatic-hormone-sensitive-prostate-cancer 2026-09-12T13:20:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-reduces-risk-recurrence-younger-patients-early-breast-cancer-natalee-subgroup-analysis 2026-09-12T13:20:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-data-asco-and-eha-showcase-momentum-pioneering-portfolio-promising-pipeline 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-accelerated-approval-vanrafia-atrasentan-first-and-only-selective-endothelin-receptor-antagonist-proteinuria-reduction-primary-iga-nephropathy-igan 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-radioligand-therapy-pluvicto-earlier-use-chemotherapy-psma-positive-metastatic-castration-resistant-prostate-cancer 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-present-new-data-aan-including-seven-year-disability-outcomes-and-safety-analysis-kesimpta-people-relapsing-multiple-sclerosis 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-third-fda-approval-oral-fabhalta-iptacopan-first-and-only-treatment-approved-c3-glomerulopathy-c3g 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-named-first-ever-corporate-pharmaceutical-partner-national-football-league 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-presentations-aaaai-and-aad-underscore-commitment-advancing-treatment-hidradenitis-suppurativa-hs-and-chronic-spontaneous-urticaria-csu 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/early-detection-game-changer-novartis-makes-bold-play-prioritize-breast-health-and-inspire-new-wave-breast-cancer-screenings 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/longer-term-novartis-kisqali-natalee-data-show-durable-reduction-distant-recurrence-broad-population-patients-early-breast-cancer 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/longer-term-data-novartis-scemblix-reinforce-superior-efficacy-favorable-safety-and-tolerability-profile-adults-newly-diagnosed-cml 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-new-96-week-results-from-phase-iii-scemblix-asc4first-trial-ash-and-late-breaking-analysis-from-phase-iii-kisqali-natalee-trial-sabcs 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-scemblix-fda-approved-newly-diagnosed-cml-offering-superior-efficacy-and-favorable-safety-and-tolerability-profile 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-oral-fabhalta-iptacopan-sustained-clinically-meaningful-results-one-year-phase-iii-c3-glomerulopathy-c3g-trial 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ribociclib-kisqali-recognized-category-1-preferred-breast-cancer-adjuvant-treatment-nccn-clinical-practice-guidelines-oncology-nccn-guidelines 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-positive-chmp-opinion-kisqali-help-reduce-risk-recurrence-people-hrher2-early-breast-cancer 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-data-relapsing-ms-reinforce-benefits-kesimpta-first-line-and-switch-patients 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-kisqali-reduce-risk-recurrence-people-hrher2-early-breast-cancer 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-shows-deepening-benefit-new-analysis-reducing-risk-recurrence-285-broad-population-patients-early-breast-cancer 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-begins-construction-two-new-radioligand-therapy-facilities-us-expanding-its-world-class-rlt-manufacturing-and-supply-network 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-accelerated-approval-fabhalta-iptacopan-first-and-only-complement-inhibitor-reduction-proteinuria-primary-iga-nephropathy-igan 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-scemblix-granted-fda-priority-review-treatment-adults-newly-diagnosed-cml 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-scemblix-phase-iii-data-first-show-superior-efficacy-favorable-safety-and-tolerability-profile-vs-standard-care-tkis-adults-newly-diagnosed-cml 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/latest-analysis-novartis-natalee-study-shows-kisqali-reduces-risk-cancer-recurrence-early-breast-cancer-patients-high-risk-node-negative-disease 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-atrasentan-phase-iii-data-show-clinically-meaningful-proteinuria-reduction-further-advancing-companys-iga-nephropathy-igan-portfolio 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-latest-phase-iii-fabhalta-iptacopan-data-c3-glomerulopathy-c3g-showing-clinically-meaningful-and-statistically-significant-351-proteinuria-reduction-vs-placebo 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-pioneering-innovation-cml-data-from-scemblix-phase-iii-asc4first-study-newly-diagnosed-patients-asco-and-eha 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-radioligand-therapy-lutathera-fda-approved-first-medicine-specifically-pediatric-patients-gastroenteropancreatic-neuroendocrine-tumors 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kesimpta-six-year-efficacy-data-show-substantial-benefits-recently-diagnosed-treatment-naive-people-relapsing-multiple-sclerosis 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-fabhalta-iptacopan-data-show-clinically-meaningful-and-statistically-significant-proteinuria-reduction-383-versus-placebo-patients-iga-nephropathy-igan 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-data-show-early-addition-twice-yearly-leqvio-inclisiran-following-maximally-tolerated-statin-therapy-significantly-reduces-ldl-c-ascvd-patients-real-world-setting 2026-09-12T19:50:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/novartis-launches-new-preferred-firm-program-legal-services 2023-11-30T11:04:46-05:00 daily 1.0 https://www.novartis.com/us-en/news/novartis-pharmaceuticals-corporation-novartis-statement-recall-outside-united-states-sandoz-generic-valsartan-and-sandoz-valsartan-and-hydrochlorothiazide-film-coated-tablets 2023-11-30T11:06:40-05:00 daily 1.0 https://www.novartis.com/us-en/news/form-483-posting-us-food-and-drug-administration-fda-novartis-statement 2023-11-30T11:05:56-05:00 daily 1.0 https://www.novartis.com/us-en/news/novartis-provides-update-use-and-safety-beovu-patients-wet-amd 2023-12-01T19:32:25-05:00 daily 1.0 https://www.novartis.com/us-en/news/life-science-companies-and-bill-melinda-gates-foundation-joint-communique 2025-05-27T03:56:51-04:00 daily 1.0 https://www.novartis.com/us-en/news/beacon-hope-addressing-health-disparities-through-holistic-community-based-collective-action 2023-11-30T10:57:12-05:00 daily 1.0 https://www.novartis.com/us-en/news/updated-packaging-now-available-sandimmune-100-mg-blister-packages 2023-11-30T10:55:26-05:00 daily 1.0 https://www.novartis.com/us-en/news/new-policy-related-340b-program 2023-11-30T10:58:49-05:00 daily 1.0 https://www.novartis.com/us-en/news/notice-healthcare-providers-and-entities 2023-11-30T11:00:05-05:00 daily 1.0 https://www.novartis.com/us-en/news/novartis-joins-accelerating-covid-19-therapeutic-interventions-and-vaccines-activ-initiative 2023-11-30T11:01:33-05:00 daily 1.0 https://www.novartis.com/us-en/news/novartis-us-response-covid-19 2023-11-30T10:58:03-05:00 daily 1.0 https://www.novartis.com/us-en/news/corrective-action-certain-100-mg-sandimmune-and-neoral-blister-packages-us 2023-11-30T11:04:09-05:00 daily 1.0 https://www.novartis.com/us-en/news/highlighting-unmet-needs-hidradenitis-suppurativa-hs 2023-11-30T10:54:28-05:00 daily 1.0 https://www.novartis.com/us-en/news/collaborating-address-disparities-cancer-screening 2023-11-30T10:53:41-05:00 daily 1.0 https://www.novartis.com/us-en/news/novartis-statement-maximum-fair-price-entresto 2024-08-15T09:31:53-04:00 daily 1.0 https://www.novartis.com/us-en/news/bringing-breakthroughs-more-patients 2025-09-29T14:20:08-04:00 daily 1.0 https://www.novartis.com/us-en/news/fda-updates-leqvio-label 2026-08-19T16:52:07-04:00 daily 1.0 https://www.novartis.com/us-en/stories/mccourty-twins-friends-shine-spotlight-sickle-cell-disease 2022-03-29T09:28:04-04:00 daily 1.0 https://www.novartis.com/us-en/stories/sourcing-innovation-strategically 2023-04-11T13:47:12-04:00 daily 1.0 https://www.novartis.com/us-en/stories/word-street-what-cell-and-gene-therapy 2022-03-29T04:11:13-04:00 daily 1.0 https://www.novartis.com/us-en/stories/day-reflection-novartis 2023-04-11T13:45:43-04:00 daily 1.0 https://www.novartis.com/us-en/stories/shaping-future-sickle-cell-disease 2022-07-21T09:54:08-04:00 daily 1.0 https://www.novartis.com/us-en/stories/novartis-looks-brightest-academic-minds-reimagine-metastatic-breast-cancer-treatment 2023-04-11T13:53:19-04:00 daily 1.0 https://www.novartis.com/us-en/stories/working-together-novartis-fight-covid-19-and-help-people-need 2023-04-11T13:54:40-04:00 daily 1.0 https://www.novartis.com/us-en/stories/reimagining-healthcare-challenging-times-novartis-society-us-report-2020 2023-04-11T13:50:28-04:00 daily 1.0 https://www.novartis.com/us-en/stories/telemedicine-helping-patients-underserved-communities-access-quality-healthcare 2022-03-29T09:16:34-04:00 daily 1.0 https://www.novartis.com/us-en/stories/understanding-heart-health-inequities-during-black-history-month 2023-04-11T13:49:02-04:00 daily 1.0 https://www.novartis.com/us-en/stories/home-app-helps-patients-stay-engaged-and-adherent-vision-monitoring-remotely 2023-04-11T14:03:46-04:00 daily 1.0 https://www.novartis.com/us-en/stories/addressing-health-inequities-starts-looking-within 2023-04-11T14:00:47-04:00 daily 1.0 https://www.novartis.com/us-en/stories/learning-connecting-and-moving-forward-together 2022-03-29T09:36:09-04:00 daily 1.0 https://www.novartis.com/us-en/stories/know-facts-and-be-advocate-prostate-cancer-awareness-month 2023-09-15T10:46:41-04:00 daily 1.0 https://www.novartis.com/us-en/stories/remembering-mens-health-national-veterans-and-military-families-month 2023-11-14T02:29:35-05:00 daily 1.0 https://www.novartis.com/us-en/stories/associate-volunteers-help-make-2023-multicultural-teen-corporate-mentoring-program-success 2024-07-08T11:16:12-04:00 daily 1.0 https://www.novartis.com/us-en/stories/journey-compassion-from-pharmacy-oncology-sales 2024-07-29T15:34:15-04:00 daily 1.0 https://www.novartis.com/us-en/stories/negative-impact-ira-patient-access-innovative-treatments 2024-08-15T09:44:23-04:00 daily 1.0 https://www.novartis.com/us-en/stories/learning-from-experiences-chronic-myeloid-leukemia-cml-community 2026-01-09T12:08:52-05:00 daily 1.0 https://www.novartis.com/us-en/stories/advancing-prostate-cancer-care-a-bold-new-partnership-helping-patients 2025-02-18T09:01:25-05:00 daily 1.0 https://www.novartis.com/us-en/stories/novartis-joins-susan-g-komen-first-its-kind-breast-cancer-policy-coalition 2025-03-12T18:05:54-04:00 daily 1.0 https://www.novartis.com/us-en/stories/autoimmune-diseases-disproportionately-impact-women-heres-why-matters 2025-05-13T15:15:54-04:00 daily 1.0 https://www.novartis.com/us-en/stories/addressing-elevated-lipoproteina-importance-testing-risk-patients 2025-08-29T10:05:52-04:00 daily 1.0 https://www.novartis.com/us-en/stories/victor-bulto-time-100-health-summit-oncology 2025-05-23T09:13:10-04:00 daily 1.0 https://www.novartis.com/us-en/stories/how-were-reimagining-cancer-care-next-generation-patient 2025-05-21T11:56:15-04:00 daily 1.0 https://www.novartis.com/us-en/stories/garage-innovation-hub 2025-05-23T09:32:06-04:00 daily 1.0 https://www.novartis.com/us-en/stories/how-katy-patient-turned-advocate-found-her-purpose 2025-06-02T11:34:58-04:00 daily 1.0 https://www.novartis.com/us-en/stories/3-ways-were-innovating-advanced-prostate-cancer-care 2025-06-16T12:20:50-04:00 daily 1.0 https://www.novartis.com/us-en/stories/3-innovative-ways-were-reaching-patients-beyond-our-medicines 2025-06-24T11:26:21-04:00 daily 1.0 https://www.novartis.com/us-en/stories/living-with-sjogrens-disease-one-womans-story 2025-10-01T15:55:17-04:00 daily 1.0 https://www.novartis.com/us-en/stories/high-lipoprotein-a-patient-story 2025-08-07T10:01:24-04:00 daily 1.0 https://www.novartis.com/us-en/stories/take-5-reshema-kemps-polanco-novartis-cco 2025-08-29T09:56:58-04:00 daily 1.0 https://www.novartis.com/us-en/stories/novartis-biomedical-research-hub-san-diego-thierry-diagana 2025-09-10T06:24:14-04:00 daily 1.0 https://www.novartis.com/us-en/stories/novartis-san-diego-research-development-innovation 2025-08-25T15:55:25-04:00 daily 1.0 https://www.novartis.com/us-en/stories/what-are-genetically-targeted-technologies-gtts 2025-09-17T10:31:29-04:00 daily 1.0 https://www.novartis.com/us-en/stories/treating-CML-chronic-myeloid-leukemia 2026-01-27T13:35:01-05:00 daily 1.0 https://www.novartis.com/us-en/stories/advanced-prostate-cancer-social-worker-support 2025-09-17T11:11:54-04:00 daily 1.0 https://www.novartis.com/us-en/stories/five-questions-katie-mazuk-novartis-us-chief-patient-experience-officer 2025-10-20T10:31:14-04:00 daily 1.0 https://www.novartis.com/us-en/stories/novartis-breast-cancer-how-women-feel-breasts 2025-10-03T10:42:06-04:00 daily 1.0 https://www.novartis.com/us-en/stories/high-lipoproteina-explained-what-you-need-know-about-hidden-emerging-indicator-heart-disease 2025-10-09T15:13:20-04:00 daily 1.0 https://www.novartis.com/us-en/stories/how-to-bridge-care-gaps-prostate-cancer 2025-10-22T15:28:33-04:00 daily 1.0 https://www.novartis.com/us-en/stories/veteran-delivers-cancer-treatment-to-patients 2025-11-11T12:38:22-05:00 daily 1.0 https://www.novartis.com/us-en/stories/novartis-teen-mentoring-program-changing-lives 2025-11-07T09:39:41-05:00 daily 1.0 https://www.novartis.com/us-en/stories/five-questions-eden-wells-chief-insights-and-decision-science-officer-novartis-us 2025-11-13T15:44:09-05:00 daily 1.0 https://www.novartis.com/us-en/stories/community-health-meeting-people-where-they-are 2025-11-17T14:57:57-05:00 daily 1.0 https://www.novartis.com/us-en/stories/innovating-america-new-rlt-manufacturing-site 2026-01-15T14:22:04-05:00 daily 1.0 https://www.novartis.com/us-en/stories/novartis-north-carolina-manufacturing-expansion 2026-01-22T15:26:22-05:00 daily 1.0 https://www.novartis.com/us-en/stories/five-questions-des-creary-novartis-us-chief-customer-engagement-officer 2026-03-06T16:44:32-05:00 daily 1.0 https://www.novartis.com/us-en/stories/victor-bulto-and-thierry-diagana-named-2026-time100-health-list 2026-02-11T13:52:10-05:00 daily 1.0 https://www.novartis.com/us-en/stories/whats-next-neuroscience-drug-discovery-conversation-genetic-medicine-head-bryan-laffitte 2026-02-23T12:49:51-05:00 daily 1.0 https://www.novartis.com/us-en/stories/power-precision-using-ai-navigate-future-prostate-cancer-care 2026-02-24T12:35:09-05:00 daily 1.0 https://www.novartis.com/us-en/stories/future-of-treating-autoimmune-disease-christy-siegel 2026-07-15T12:50:49-04:00 daily 1.0 https://www.novartis.com/us-en/stories/could-we-end-preventable-heart-disease-our-lifetime-novartis-leaders-explore-time100-health-event 2026-03-11T10:18:39-04:00 daily 1.0 https://www.novartis.com/us-en/stories/future-treating-autoimmune-diseases-science-tech-patients-driving-progress 2026-03-31T16:41:45-04:00 daily 1.0 https://www.novartis.com/us-en/stories/susans-story-i-never-imagined-id-be-someone-who-had-heart-attack 2026-04-20T14:14:41-04:00 daily 1.0 https://www.novartis.com/us-en/stories/carter-jaynes-novartis-deliver-rlt-to-cancer-patients 2026-06-05T14:09:36-04:00 daily 1.0 https://www.novartis.com/us-en/stories/Novartis-investment-america-inclusive-health-accelerators 2026-05-18T15:24:18-04:00 daily 1.0 https://www.novartis.com/us-en/stories/stroke-awareness-month-what-you-should-know-about-your-stroke-risk 2026-05-14T13:39:35-04:00 daily 1.0 https://www.novartis.com/us-en/stories/understanding-breast-cancer-recurrence-risk 2026-06-23T11:23:24-04:00 daily 1.0 https://www.novartis.com/us-en/stories/meet-colin-novartis-scientist-looking-new-breakthroughs 2026-07-07T13:50:05-04:00 daily 1.0 https://www.novartis.com/us-en/stories/novartis-next-generation-cancer-care-survey 2026-05-28T15:14:46-04:00 daily 1.0 https://www.novartis.com/us-en/stories/new-survey-reveals-4-things-patients-hs-really-need 2026-06-03T12:59:19-04:00 daily 1.0 https://www.novartis.com/us-en/stories/carrie-ann-inaba-sjogrens-disease 2026-06-12T10:44:41-04:00 daily 1.0 https://www.novartis.com/us-en/stories/new-heart-health-information-patients-need-know-understanding-2026-cholesterol-guidelines 2026-08-17T13:12:06-04:00 daily 1.0 https://www.novartis.com/us-en/stories/novartis-marks-30-years-breakthroughs-building-250-years-discovery-reimagine-what-medicine-can-do-next 2026-08-06T09:53:13-04:00 daily 1.0 https://www.novartis.com/us-en/stories/diagnosing-hidradenitis-suppurativa-new-tool-help-patients 2026-09-09T16:54:55-04:00 daily 1.0 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076114-automation-engineer-ai-digital-manufacturing-automatisierungsingenieur-ki-digitale-fertigung-de-de 2026-07-08T09:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081099-area-business-manager-mwd-rlt-gebiet-leipzig-halle-magdeburg-de-de 2026-08-26T15:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081096-area-business-manager-mwd-rlt-gebiet-heidelberg-mainz-ludwigshafen-de-de 2026-09-07T14:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081403-equipment-specialist-mwd-80-de-de 2026-07-01T15:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080902-operational-excellence-opex-expert-fmd-temporary-de-de 2026-07-01T15:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078731-validation-expert-mfd-de-de 2026-07-14T07:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082114-elektrotechniker-wmd-de-de 2026-08-06T10:31:24+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079444-automation-engineer-ai-digital-manufacturing-automatisierungsingenieur-ki-digitale-fertigung-de-de 2026-07-22T10:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071882-specialist-upravljanja-kakovosti-za-podrocje-skladnosti-racunalniskih-sistemov-qa-ecompliance-specialist-mfd-sl-si 2026-07-22T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076045-operater-mzd-sl-si 2026-09-11T09:34:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076808-tehnik-v-proizvodnji-farmacevtskih-ucinkovin-mzd-sl-si 2026-07-22T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080867-operater-na-pakiranju-mzd-sl-si 2026-07-22T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082217-laboratorijski-analitik-iii-mzd-qc-analyst-iii-mfd-sl-si 2026-07-22T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083483-laboratorijski-analitik-ii-mzd-sl-si 2026-08-13T07:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083429-shift-lead-ii-mwd-temporary-de-de 2026-08-12T22:31:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085275-equipment-operator-ii-de-de 2026-08-13T10:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10047858-product-manager-hf-en-alternance 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10059989-sales-executive 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065561-early-talents 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067189-executive-assistant-coordinator 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067047-manufacturing-science-technology-experts 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10062245-director-integrated-field-insights-analytics 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069051-head-corporate-comms 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069390-expert-science-technology-ii 2026-09-12T17:32:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068813-manager-scientific-writing 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070616-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073919-maintenance-technician 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074210-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-09-12T17:32:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071967-qc-analyst 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068634-medical-information-agent 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074406-project-engineer 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070332-mechaniker-mfd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069404-enterprise-security-architect-data-security 2026-09-07T08:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075196-vodja-ekipe-za-mednarodno-trgovino-mzd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075081-isotope-project-lead-associate-director-st 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074786-clinical-sciences-trial-leader 2026-09-12T17:32:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074784-clinical-sciences-associate-director 2026-09-12T17:32:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075311-technicien-de-production-hf 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076113-elektrotechniker-instandhaltung-mfd-novartis-pharmaceutical-manufacturing-gmbh-kundl-austria 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075784-head-legal-value-access 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074724-laboratorijski-analitik-mzd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075486-head-engineering-texas-ad-level 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075487-head-engineering-florida-ad-level 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076381-mehanik-mzd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076613-tmdp-china-head 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075344-head-tco-translational-clinical-oncology-china 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076871-allergy-territory-account-specialist-denver-lincoln 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077296-operater-mzd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077149-associate-director-translational-medicine-expert-tm-clinical-pharmacology 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077580-tartimgranulasyon-operatoru-gecici 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077587-ambalaj-blisterlemekutulama-operatoru-gecici 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077588-kaplama-operatoru-gecici 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077017-senior-product-expert-cdp 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077192-data-lead-marketing-platform-ops-msm 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077508-neuroscience-territory-account-specialist-san-jose-ca-1-2 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074363-director-product-strategy-value-realization 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077783-expert-science-technology-iii 2026-09-12T17:32:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073874-global-gmp-senior-quality-auditor 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074378-add-early-development-physiciancvm 2026-09-12T17:32:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076941-manufacturing-system-expert-pas-x-mfd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071400-senior-sales-executive-hematology 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077208-calibration-technician-hvac-mwd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075924-pk-director-linchuangyaolizongjian 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078378-ldc-deployment-manager-manufacturing 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077906-operater-v-enoti-pakiranja-mzd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076046-strategic-value-access-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077754-director-preclinical-safety-toxicology-china-head 2026-09-12T17:32:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075203-associate-director-pk-scientistclinical-pharmacologist 2026-09-12T17:32:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077221-specialist-mbr-designer 2026-09-05T09:33:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078184-vodja-validacij-mzd-validation-lead-mfd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077047-customer-excellence-capability-building-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078854-manager-bsi-field-design-advisory 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076440-tehnik-v-proizvodnji-farmacevtskih-ucinkovin-mzd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078492-sr-specialist-ddit-ops-site-automation-expert 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078732-tehnik-inzeniringa-lokacije-i-mzd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079049-senior-quality-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078734-tehnolog-proizvodnega-inzeniringa-lokacije-ii-mzd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076995-director-chemistry-scientific-due-diligence 2026-09-12T17:32:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069085-g2g-young-professional 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078162-laboratorijski-analitik-mzd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077584-defensive-cyber-security-researcher 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078361-pricing-access-contracting-head 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079676-account-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073414-laboratorijski-analitik-mzd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077829-pricing-access-contracting-lead 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078951-vice-president-head-us-medical-immunology 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078867-early-clinical-development-physician-oncology 2026-09-12T17:32:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079079-analitik-oskrbovalne-verige-scm-analyst-mzd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079425-production-support-engineer 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079554-brand-manager-immunology 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079426-production-support-engineer 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078870-skladiscnik-mzd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079829-global-clinical-operations-site-partnership-manager 2026-09-12T17:32:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079254-senior-manager-technical-legal-technology 2026-09-07T16:33:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078169-automation-engineer 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079283-senior-legal-counsel-core-legal-legal-innovation-hub 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077489-medical-science-liaison-crm 2026-09-05T09:33:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079078-tehnolog-proizvodnega-inzeniringa-lokacije-mfd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079235-precision-medicine-director 2026-08-17T16:31:24+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079741-associate-director-content-approval-operations 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080334-precision-medicine-director 2026-08-17T16:31:24+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078853-senior-manager-internal-audit 2026-09-12T05:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079993-senior-manager-animal-welfare-integrity-assurance 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079571-dermatology-territory-account-specialist-portland-west 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080456-data-management-infrastructure-lead 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080433-app-charge-de-developpement-des-competences 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079457-senior-specialist-platform-services 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079987-senior-expert-i-data-science 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079981-senior-principal-scientist-assoc-director-oncology-translational-research 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077265-commercial-portfolio-lead 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077361-ta-access-strategy-head 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077052-manager-compliance 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080264-director-program-management 2026-09-12T05:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080862-senior-analyst-marketing-platform-operations 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078782-audit-and-compliance-specialist 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080052-ast-specialist 2026-09-05T09:33:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080344-principal-scientist-i-or-ii-pk-sciences-therapeutic-areas-multiple-listings 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079661-skrbnik-osnovnih-podatkov-materialov-site-master-data-expert-mzd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080781-director-crm-product-owner-4-openings 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080248-principal-scientist-iisenior-principal-scientist-modeling-simulation-dual-level-posting 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079722-asset-lifecycle-specialist 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079691-access-field-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10062691-associate-director-physics-team-leader-and-process-automation 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076132-site-itot-ai-champion 2026-09-01T15:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079552-translational-medicine-expert-dermatology-associate-director 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081077-translational-medicine-expert-dermatology-associate-director 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079898-associate-director-regulatory-diagnostics 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074221-senior-expert-engineering-device-development 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078604-quality-assurance-operations-specialist 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074569-congress-and-digital-channel-partner 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079985-director-group-head-ai-systems-scale 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079914-director-and-group-head-applied-ai 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081542-medical-science-liaison-msl-neuromuscular-wa-or-remote 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081081-associate-director-content-workflow-controls 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081541-medical-science-liaison-msl-neuromuscular-la-az-remote 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081464-senior-analyst-marketing-platform-operations 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080722-senior-principal-statistical-programmer 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080297-access-field-head-states 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081713-tablet-baski-operatoru-gecici 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081463-senior-analyst-marketing-platform-operations 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081032-associate-director-statistical-programming 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080461-tehnik-inzeniringa-lokacije-v-proizvodni-trdnih-izdelkov-mzd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080761-associate-director-data-science 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079819-koordinator-sprememb-potiskane-ovojnine-mzd-artwork-change-coordinator-mfd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079266-data-science-cheminformatics-ai-lab-loop-hit-finding 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081600-access-contracting-manager-private-hospital-partnerships 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076496-sr-project-manager-engineering 2026-09-08T10:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081548-medical-excellence-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081079-head-production-and-operations-millburn 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080967-manager-qa-method-validation 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081882-senior-hospital-access-strategy-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080723-qc-analyst 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080477-regional-category-manager-commercial-it 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081536-senior-clinical-research-associate-remote-field-based 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081774-medical-advisor-bc 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082139-satis-temsilcisi-onkoloji-konya 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080302-quality-assurance-team-lead-quality-laboratory-systems-qls 2026-09-05T09:33:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081408-principal-scientist-iisenior-principal-scientist-pk-sciences-clinical-pharmacology-artificial-intelligence-ai-lead-dual-level-posting 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082078-medical-science-liaison-autoimmune-car-t-vancscga 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081968-dermatology-territory-account-specialist-portland-east 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081905-senior-expert-science-technology-extractables-and-leachables 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078510-comptable-fiscaliste-senior-hf 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081073-medical-science-liaison-msl-neuroimmunology-neurodegeneration-ny-state-buffalosyracuserochester 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071479-brand-manager-ipa 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077349-integrated-insights-business-partner 2026-09-05T09:33:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082311-production-head 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082593-brand-manager-hematology 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080850-senior-specialist-platform-services-aws 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081325-senior-scientist-i-translational-medicine-pks-adme 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082085-innovation-postdoctoral-fellow-dna-damage-repair 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082321-access-field-manager-delhi 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082729-process-documentation-specialist 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10058282-japan-program-clinical-head-crm 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080335-precision-medicine-director 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079693-access-field-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081689-product-steward 2026-09-08T10:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082197-senior-brand-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079656-global-labelling-associate-director-content-established-products 2026-08-16T20:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079651-global-labelling-associate-director-content-cardiovascular-renal-metabolism 2026-08-16T19:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081318-associate-director-adc-platform-oncology-drug-discovery 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081840-patent-attorney 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080973-patent-attorney 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081002-process-validation-expert 2026-09-05T09:33:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082739-global-labelling-associate-director-content-established-products 2026-08-16T20:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082962-stg-ai-solutions-automation-engineer 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082979-site-mst-head-aseptics-ljubljana-mfd-vodja-proizvodnih-znanosti-tehnologij-aseptika-ljubljana-mzd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082800-discovery-postdoctoral-fellow-neuroscience 2026-08-21T18:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080349-director-ai-foundations-engineer-remote 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083019-medical-science-liaison-bc 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081241-tehnik-v-proizvodnji-farmacevtskih-ucinkovin-mzd 2026-08-21T06:31:21+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079489-medical-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082791-cardiovascular-territory-account-specialist-tallahassee-gainesville 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077826-principal-engineer-mst 2026-09-08T10:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080566-associate-director-access-reimbursement-adar-cv-thousand-oaks-ca 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080589-associate-director-access-reimbursement-adar-cv-west-texas 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081566-director-study-quality-and-compliance-nonclinical-safetytoxicology 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081568-principal-scientist-iii-study-quality-and-compliance-nonclinical-safetytoxicology 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082599-medical-science-liaison-cluj 2026-09-05T09:33:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079403-principal-scientist-ii-pharmacology 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082813-senior-automation-engineer-high-throughput-screening 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081257-laboratorijski-analitik-iii-mzd 2026-09-10T07:31:43+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082558-data-scientist-ai-biomedical-imaging 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082604-principal-scientist-early-pipeline-development 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080819-shift-supervisor 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082786-renal-rare-territory-account-specialist-baltimore-md 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082983-procurement-category-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080629-cardiovascular-territory-account-specialist-concord-nh 2026-09-03T21:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082647-business-operations-lead-discovery-sciences 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082637-principal-scientist-i-soluble-biomarkers-molecular-cellular-sciences-mcs 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083446-process-expert 2026-09-05T09:33:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083445-manufacturing-system-expert 2026-09-05T09:33:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083046-quality-assurance-officer-operations 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083298-retail-marketing-lead 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083548-senior-bpa-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080620-cardiovascular-territory-account-specialist-nashville-tn 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082990-qp-quality-lead-pilot-plant 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081353-qc-analyst-ii-labortechniker-mfd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076048-tehnik-v-proizvodnji-farmacevtskih-ucinkovin-mzd 2026-08-25T08:32:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083304-hse-engineer 2026-09-12T05:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083555-associate-director-enterprise-architect-network-security 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083150-associate-director-enterprise-architect-network-security 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083559-associate-director-enterprise-architect-network-security 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082822-cardiovascular-territory-account-specialist-peoria-il 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076681-it-sr-business-analyst-cdmo 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082687-cardiovascular-territory-account-specialist-wichita-ks 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080644-cardiovascular-territory-account-specialist-springfield-mo 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081288-product-expert-content-enablement-platforms 2026-09-07T18:32:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083597-dermatology-territory-account-specialist-seattle-wa 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082679-principal-scientist-analytics-team-lead 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082945-associate-director-search-evaluation 2026-09-12T05:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082756-manager-market-access 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083155-due-diligence-director-china 2026-09-12T05:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077779-strategic-security-senior-analyst 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083159-director-bdl-tx-china 2026-09-12T05:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083160-director-alliance-management 2026-09-12T05:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081991-associate-director-alliance-mgt-china 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083154-director-search-evaluation 2026-09-12T05:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083682-qualified-person-qp 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077720-clinical-development-director-renal 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083660-clinical-data-strategy-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082102-principal-scientist-ii-biomarker-lead 2026-09-02T00:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072428-tehnik-vzdrzevanja-v-proizvodnem-inzeniringu-mfd-maintenance-technician-manufacturing-engineering-mfd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076867-rd-quality-lead 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077262-senior-manager-internal-audit-tech-ops 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083210-heor-lead 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083609-rheumatology-institutional-specialist-new-york-city 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083237-data-engineering-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083869-vodja-tehnoloskih-prenosov-mzd-technical-transfer-lead-mfd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083829-senior-expert-science-technology 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083923-capability-building-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077143-dermatology-territory-account-specialist-newark-cherry-hill-philly 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083775-manager-market-access-va 2026-09-02T11:31:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083777-manager-market-access-va 2026-09-02T11:31:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083974-bsi-head-heor 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083626-site-qc-head-associate-director 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083725-qualified-person-qp 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081943-trd-qa-global-sterility-assurance 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078280-process-specialist 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079747-rheumatology-territory-account-specialist-jersey-city 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083625-head-qa-operations-assoc-dir-level 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084064-neuroscience-territory-account-specialist-new-york-city 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081797-zhangaizhecaiyong-associate-mrqiyuesheyuan 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081992-associate-director-cbd-ops-china 2026-09-12T05:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082000-tehnik-vzdrzevanja-mzd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082920-raziskovalec-mst-mzd-scientist-mst-mfd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082969-senior-expert-parenteral-packaging 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078236-rheumatology-institutional-specialist-miami 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079746-rheumatology-territory-account-specialist-manhattan 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083139-qa-operations-lead 2026-09-02T04:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083720-head-quality-systems-and-compliance-assoc-dir 2026-09-08T10:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084332-lernender-kauffrau-mann-eba 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084314-lernender-laborantin-efz-fachrichtung-chemie 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084325-lernender-chemie-und-pharmatechnologe-technologin-efz 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084328-lernender-logistikerin-efz 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084330-lernender-laborantin-efz-fachrichtung-biologie 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084331-lernender-kauffrau-mann-efz 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080790-data-ai-analytics-platforms-manager-mwd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077179-medical-representative-disease-area-specialist-renal 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082036-regional-accounts-associate-director-neuromuscular-southern-california 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083243-manufacturing-unit-lead-drug-substance 2026-09-08T10:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081340-occupational-health-specialist 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084421-lernender-tierpflegerin-efz-fachrichtung-versuchstiere 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083901-msl-lead 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083873-scm-tactical-planner-rlt 2026-08-25T05:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084257-discovery-postdoctoral-fellow-sarna-biology 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084402-senior-clinical-development-medical-director 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084261-senior-sales-representative 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079033-senior-clinical-development-medical-director 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081988-associate-director-due-diligence-china 2026-09-12T05:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079978-associate-director-it-project-manager-physical-protective-security 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083505-director-global-trd-qa-sterility-assurance 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083507-director-global-trd-qa-sterility-assurance 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077239-senior-manager-internal-audit 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082557-discovery-postdoctoral-fellow-display-technology-target-identification-and-mechanistic-biology 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078387-health-safety-environmental-business-partnerlevel-1-prevention-advisor 2026-08-27T14:31:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084465-menedzher-napravleniya-effektivnosti-polevykh-sil 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077269-integrated-insights-lead 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081224-warehouse-shipping-specialist 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084622-sales-head-immunology 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084378-executive-director-product-strategy-lead-cardiovascular 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084124-qc-analyst-ii 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084131-therapeutic-area-head-pk-sciences-immunology 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083807-director-data-analytics-integration-eventing-platforms 2026-08-26T09:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074007-director-analytics-infrastructure-pipeline-operations 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084464-commercial-va-field-excellence-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074001-director-analytics-standards-impact-measurement 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083238-account-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083473-qa-compliance-specialist 2026-09-05T09:33:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084389-cardiovascular-territory-account-specialist-boulder-co 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084589-data-science-ai-innovation-postdoctoral-fellow 2026-08-25T21:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083751-cardiovascular-territory-account-specialist-omaha-ne 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084545-senior-expert-downstream-process-development-functional-lead 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080812-clinical-data-strategy-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080633-cardiovascular-territory-account-specialist-sioux-falls-sd-rochester-mn 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084648-medical-science-liaison 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066986-legal-intern 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084541-senior-scientific-engagement-program-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084652-medical-science-liaison 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083060-trd-qa-team-lead-biologics-cmc-mfd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084528-senior-graphic-designer 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084710-account-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084416-senior-scientific-operations-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068341-odgovorna-oseba-za-sproscanje-zdravil-na-trg-mzd-qp-mfd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065908-senior-expert-science-technology-downstream-process-development 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084450-integrated-insights-business-partner 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083837-technician-ii-maintenance-and-reliabilities-utility-operations 2026-09-08T10:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077475-execution-excellence-head 2026-09-05T09:33:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082930-people-partner 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083935-associate-director-oncology-priority-accounts-denverkansas-cityst-louis 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082801-quality-team-leader-qa-compliance 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084697-senior-director-sterility-assurance 2026-09-12T05:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084727-director-data-products-platform-innovation-adoption 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084743-head-legal-ta-immunology-and-crm-international 2026-09-02T00:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084561-sr-manager-manufacturing-execution-systems-mes 2026-09-08T10:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084785-oncology-territory-account-specialist-solid-tumor-ventura-ca 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084559-data-management-infrastructure-associate 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084953-medical-advisor-hema 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084873-senior-managerassociate-director-ta-communications-patient-advocacy 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084882-medical-representative-cardiovascular-hcm 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084964-msl-lead-bc-north 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080294-senior-medical-representative-cardiovascular-metabolism-binh-duong 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078143-ddit-business-partner-analyst 2026-08-20T06:31:43+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084742-sso-associate-clinical-project-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084647-medical-science-liaison 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084995-dermatology-territory-account-specialist-ventura 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084323-business-excellence-lead-huntingtons-disease 2026-08-31T15:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084558-global-program-head 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084669-neuroscience-territory-account-specialist-southern-tucson-phoenix 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084805-manager-data-governance 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084924-account-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084745-value-access-and-pa-head-levant 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083882-access-field-manager-slaskie-dolnoslaskie-lodzkie-opolskie 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079023-rheumatology-territory-account-specialist-asheville 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082653-recruitment-business-partner-france-italy-spain-global-health-hf 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079932-qualified-person-qpsachkundige-person-mwd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084824-associate-dir-search-evaluation-platforms-ai 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084148-senior-principal-scientistassociate-director-clinical-pbpk-dual-level-posting 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085094-neuroscience-territory-account-specialist-san-francisco-sacramento 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084073-itot-lab-specialist 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085072-manager-cardiovascular-priority-accounts-iowa 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082695-innovation-postdoctoral-fellow-data-science-ai-vision-foundation-models-cellular-imaging-ai-drug-discovery 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085109-laboratorijski-analitik-ii-qc-analyst-ii 2026-09-11T05:32:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084965-sales-representative-neuroscience-central-south-area 2026-09-03T10:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084319-strateski-vodja-kljucnih-strank-strategic-account-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085160-integrated-insight-business-partner-mwd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085057-principal-scientist-ii-translational-biomarker-strategy-lead 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084918-patent-attorney 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083266-qa-operations-specialist-shift-based 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084348-adme-scientist-antibody-oligonucleotide-conjugates-principal-scientist-iii 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079710-radioligand-therapies-rlt-sales-specialist-prostate-green-bay 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082664-manager-cardiovascular-priority-accounts-houston 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083783-tehnolog-proizvodnih-procesov-i-opticna-kontrola-mzd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085053-ekspert-procesnih-tehnologij-za-primarno-ovojnino-medicinske-pripomocke-mzd-technical-steward-primary-packaging-material-and-medical-devices-mfd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084195-ekspert-upravljanja-kakovosti-objekti-oprema-mzd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084667-director-executive-director-modeling-simulation-dual-level-posting 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079732-senior-expert-senior-principal-pks-data-scientist-scientific-software-engineer-dual-level-posting 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085280-innovation-postdoctoral-fellow-lysosomal-lipid-biology-and-neurodegeneration 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077299-commercial-portfolio-head 2026-09-05T09:33:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084825-director-search-evaluation-platforms-ai 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085293-join-novartis-talent-community-national-sales-network-nsn-2026 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085087-dermatology-territory-account-specialist-boise-idsalt-lake-city-ut 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085328-qc-specialist-functional-lead-mwd 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085144-content-activation-oce-orchestration-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081667-access-and-reimbursement-manager-nps-renal-seattle-wa 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085390-associate-director-translational-modeling-simulation 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082680-research-scientist-bioanalyticsspr 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082387-omnichannel-associate 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081865-head-talent-development-japan 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084719-senioradvanced-medicalsales-representative 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084706-senior-expert-science-technology-analytical-operations 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081868-logistics-coordinator-2 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085407-portfolio-account-specialist-cardio-nsw-south-west 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078885-global-labelling-director-team-lead-content 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084663-vodja-skupine-kontrole-kakovosti-mzd 2026-09-11T07:33:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085292-cardiovascular-territory-account-specialist-arnold-mo 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084841-ed-product-strategy-lead-ms 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085076-neuroscience-territory-account-specialist-cincinnati-ohlexington-ky 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085093-cardiovascular-territory-account-specialist-minneapolis-mn 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079431-portfolio-account-specialist-immunology-qld-wa 2026-09-08T05:34:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084887-senior-analyst-enterprise-competitive-intelligence 2026-08-18T06:31:19+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085372-associate-director-access-reimbursement-oncologyneuro-north-texas 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085085-data-science-ai-innovation-postdoctoral-fellow 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083909-ddit-ops-robotics-expert-itot 2026-09-12T11:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085129-site-automation-leader 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084077-country-value-access-head 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082420-associate-clinical-programmer-clinical-study-data-risk-based-quality-management-monitoring 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082435-expert-clinical-programmer-clinical-study-data-risk-based-quality-management-monitoring 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083816-ip-search-analytics-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084254-senior-principal-scientist-associate-director-soluble-biomarkers-molecular-cellular-sciences-mcs 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082452-medical-science-liaison-ta-oncology-radioligand-therapy 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082742-global-labelling-associate-director-content-cardiovascular-renal-metabolism 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082744-global-labelling-director-team-lead-content 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077041-area-sales-manager-neuro-oncology-hematology 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084469-ip-search-analytics-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085547-innovation-postdoctoral-fellow-peptide-or-lmw-delivery-new-drug-modality 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10064030-sr-automation-engineer-drug-product 2026-09-08T17:33:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085397-associate-director-psc-program-monitoring 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085595-senior-brand-manager-ipa 2026-09-04T06:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084515-sales-rep-institutional-territory-business-executive-senior-territory-business-executive-area-sales-manager-crm 2026-09-11T07:33:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084845-sales-rep-territory-business-executive-crm 2026-09-11T07:33:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085499-coordinator 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084572-sales-rep-territory-business-executive 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084501-sales-rep-institutional-territory-business-executive-crm 2026-09-11T07:33:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083217-sales-rep-territory-business-executive 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084876-sales-rep-territory-business-executive-crm 2026-09-11T07:33:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084507-sales-rep-territory-business-executive 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084500-sales-rep-territory-business-executive-crm 2026-09-11T07:33:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084503-sales-rep-institutional-territory-business-executive-crm 2026-09-11T07:33:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083331-sales-rep-territory-business-executive 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083417-area-manager-regional-business-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083865-regional-business-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084508-sales-rep-institutional-territory-business-executive-crm 2026-09-11T07:33:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083212-territory-business-executive 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083962-area-manager-institutional-regional-business-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080782-director-technical-project-leader 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085575-neuroscience-regional-director-west 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085544-threat-detection-response-senior-specialist 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084993-qa-compliance-expert-analytics 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084994-qa-compliance-expert-general-compliance 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076782-medical-science-liaison-cardiovascular-boston-ma-territory 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080552-ad-access-reimbursement-adar-cv-minneapolis-mn 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080387-principal-clinical-data-scientist 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085395-access-reimbursement-manager-allergy-louisville-ky-indianapolis 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084969-senior-medical-representative-neuroscience-ha-noi 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085342-lead-data-scientist-gen-ai-expert 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085584-area-sales-manager-oncology 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085526-brand-manager-hematology 2026-08-21T15:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085756-ta-access-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082357-junior-facility-management-specialist 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077144-commercial-portfolio-lead 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085505-brand-manager-i-neurology 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076590-shipping-and-receiving-specialist-night 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079964-warehouse-inventory-control-logistics-specialist 2026-09-08T10:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085127-maintenance-technician-automation 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085658-allergy-area-business-leader-southeast 2026-09-08T19:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085277-medicinal-organic-chemist-chemical-biology-bs-or-ms 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085567-associate-director-thought-leader-liaison-rheumatology 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085537-associate-director-thought-leader-liaison-dermatology 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083340-sales-rep-territory-business-executive 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083184-sales-rep-institutional-territory-business-executive 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083315-sales-rep-territory-business-executive 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084247-sales-rep-territory-business-executive-crm 2026-09-11T07:33:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084301-sales-rep-territory-business-executive-crm 2026-09-11T07:33:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084505-sales-rep-territory-business-executive 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084506-sales-rep-territory-business-executive-crm 2026-09-11T07:33:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084346-senior-global-program-safety-team-lead-crm 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081092-country-proc-manager-china-commercial 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085092-clinical-project-manager 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085774-cardiovascular-territory-account-specialist-lubbock-tx 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078093-demand-planner-es-es 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076161-manufacturing-specialist-es-es 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077358-qc-analyst-hf-cdd-fr-fr 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082999-app-medical-lead-neuroscience-en-alternance-fr-fr 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083554-hospital-representative-sales-specialist-luxembourg-fr-fr 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077409-sales-marketing-head-immunology-it-it 2026-09-01T10:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065124-director-policy-ja-jp 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072504-manufacturing-specialist-ja-jp 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080437-head-tech-systems-innovation-japan-patient-safety-pharmacovigilance-ja-jp 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080994-development-regulatory-affaires-kaifayaoshi-neuroscience-gene-therapy-precision-diagnostics-ja-jp 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082103-senior-scientist-preclinical-safety-ja-jp 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084277-neuroscience-brand-manager-ja-jp 2026-08-24T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072954-site-maintenance-technician-l-specialist-compounding-nl-nl 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084968-process-expert-ru-ru 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085252-account-manager-ru-ru 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070666-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070639-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073043-msl-manager-immu-zh-cn 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073362-medical-advisor-neuroscience-zh-cn 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076261-gaojidianshangjingli-zh-cn 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073120-medical-advisor-immu-zh-cn 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077878-rd-quality-manager-zh-cn 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078990-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-09-04T10:32:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076106-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079896-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-09-04T10:32:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080368-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-09-04T10:32:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080095-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-09-04T11:32:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081103-senior-expert-science-technology-i-zh-cn 2026-09-12T11:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082263-medical-advisor-cv-zh-cn 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082262-access-field-manager-zh-cn 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082698-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083668-field-access-lead-zh-cn 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083861-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-09-04T09:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084171-hospital-access-manager-zh-cn 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084175-regional-category-manager-indirect-apac-zh-cn 2026-08-24T11:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084915-gaojidequjingli-zh-cn 2026-09-04T10:32:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084612-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-09-04T10:32:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084999-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-09-04T11:32:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084956-gaojidequjingli-zh-cn 2026-09-04T10:32:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085030-medical-science-liaison-csu-zh-cn 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085035-gaojidequjingli-zh-cn 2026-09-04T09:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085118-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-09-04T10:32:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085583-gaojidequjingli-lingshou-zh-cn 2026-08-15T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085707-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-09-04T11:32:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082709-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-09-04T10:32:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084226-expert-process-dsp-hf-fr-fr 2026-08-16T22:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085307-senior-brand-manager-bc-zh-cn 2026-09-04T06:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085846-associate-directorsenior-manager-program-management 2026-09-12T23:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085947-gaojidequjingli-zh-cn 2026-09-04T11:32:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083844-renal-rare-territory-account-specialist-dallas-tx 2026-08-17T14:31:23+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085924-rheumatology-territory-account-specialist-st-louis 2026-08-17T16:31:24+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080386-principal-scientist-i-qsp-modeling-simultion 2026-08-17T17:31:43+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084088-senior-expert-ii-data-scientist 2026-08-17T17:31:43+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082523-research-scientist-lentiviral-vector-purification-and-analytics 2026-08-17T18:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085659-allergy-territory-account-specialist-des-moines 2026-08-19T14:31:39+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085365-head-public-affairs-brazil 2026-08-17T18:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085900-cardiovascular-territory-account-specialist-kansas-city-ks 2026-08-17T19:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083833-oncology-territory-account-specialist-solid-tumor-miami-fl 2026-08-17T20:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085916-associate-director-incentive-compensation 2026-08-17T20:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085910-discovery-postdoctoral-fellow-diseases-aging-and-regenerative-medicine-dare 2026-08-17T21:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085735-cardiovascular-territory-account-specialist-waco-waxahachie-tx 2026-08-17T21:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085744-itot-head-changping 2026-09-12T23:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084868-access-field-manager 2026-08-18T03:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085026-regional-supply-chain-coordinator 2026-08-21T07:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069230-sr-procurement-ai-analytics-lead 2026-08-18T09:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085882-senior-product-specialist 2026-08-18T09:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085122-senior-expert-science-technology-iii-analytical-research-development 2026-09-12T23:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085961-medical-science-liaison-immu-zh-cn 2026-08-18T12:31:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085951-medical-science-liaison-hema-zh-cn 2026-08-18T12:31:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085800-senior-expert-science-and-technology-fmd 2026-09-03T13:31:32+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078595-specialist-za-podatkovno-znanost-ui-specialist-data-science-ai 2026-08-18T12:31:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079811-quality-team-leader-qa-operations-mwd-de-de 2026-08-18T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085487-maintenance-technician-instrumentation-de-de 2026-08-18T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085754-sourcing-manager-it-digital 2026-08-18T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085561-procurement-digital-transformation-performance-manager-es-es 2026-08-18T18:31:49+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085647-research-scientist-synthetic-technologies 2026-08-18T19:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086017-regional-director-access-reimbursement-dermatology-central-region 2026-08-18T21:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085380-medical-science-liaison-cardiovascular-michigan-territory 2026-08-18T22:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085971-senior-brand-manager-immu-zh-cn 2026-09-04T06:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082790-partenaire-hse-cdd-3-mois-hf-fr-fr 2026-08-27T09:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083414-crm-ta-head 2026-08-19T06:31:45+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078974-payroll-expert 2026-08-24T07:31:47+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086056-gaojidequjingli-zh-cn 2026-09-04T10:32:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085594-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-08-19T08:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085873-junior-manufacturing-technician 2026-08-19T09:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085855-equipment-operator-i 2026-08-24T10:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079929-director-international-policy-communications 2026-08-19T12:31:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083587-senior-expert-science-technology-downstream-process-development-modelling-mfd-sl-si 2026-08-19T13:31:19+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082779-director-data-strategy-data-products 2026-08-19T14:31:39+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084629-access-field-lead 2026-08-19T15:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075033-manufacturing-quality-assurance-specialist 2026-09-08T10:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086273-rheumatology-territory-account-specialist-memphis 2026-08-19T22:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084913-quality-team-leader-qc-hf-fr-fr 2026-09-01T09:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082267-area-sales-manager-oncology-nsw-wa 2026-08-20T01:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079434-portfolio-account-specialist-immunology-vic-west-sa 2026-08-20T02:31:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084470-external-workforce-management-process-specialist 2026-08-20T07:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085753-process-specialist 2026-08-20T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084011-operativni-vodja-resitve-arhitekture-it-mzd-associate-director-solution-architecture-mdf 2026-08-27T10:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083500-disease-area-lead-immunology 2026-08-25T12:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086042-marketing-lead-immunology 2026-09-10T05:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085773-labortechnikerin-fur-manufacturing-science-technology-mwd-50-de-de 2026-08-20T14:31:51+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085661-engineer-mst-aseptic-drug-product 2026-09-08T10:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080739-associate-director-search-evaluation-immunology 2026-08-20T17:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080936-associate-director-search-evaluation-immunology 2026-08-20T17:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085709-sr-engineer-mst-aseptic-drug-product 2026-09-08T10:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086263-dermatology-territory-account-specialist-edisontoms-river-nj 2026-08-20T20:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086115-associate-director-neuroscience-priority-accounts-new-england 2026-08-20T20:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085711-dermatology-territory-account-specialist-sacramento-ca 2026-08-20T20:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086101-regional-director-health-information-technology-west 2026-08-31T02:31:41+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086084-equipment-operator-i-mwd-de-de 2026-08-21T07:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085878-lab-equipment-engineer-ru-ru 2026-08-30T10:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086398-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-09-04T09:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085867-associate-director-data-systems-ai-enterprise-competitive-intelligence 2026-08-21T10:31:41+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085453-process-engineer-iii 2026-09-08T10:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086184-ed-workforce-user-experience 2026-08-21T15:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086149-ed-engine-lead-2-positions 2026-08-21T15:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086125-executive-director-strategy-prioritization-governance 2026-08-21T15:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086126-executive-director-us-business-strategy-lead 2026-08-21T16:31:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086340-ed-innovative-data-offerings-and-products 2026-08-21T16:31:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086290-director-strategy-engagement-lead 2026-08-21T16:31:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086291-director-strategy-engagement-lead 2026-08-21T16:31:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086127-executive-director-strategic-projects-lead 2026-08-21T16:31:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086292-director-strategy-engagement-lead 2026-08-21T16:31:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086293-director-strategy-engagement-lead 2026-08-21T16:31:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086151-ad-engine-delivery-lead-6-positions 2026-08-21T16:31:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086130-associate-director-strategy-associate 2026-08-21T16:31:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086137-associate-director-strategy-associate 2026-08-21T16:31:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086287-associate-director-governance-portfolio-lead 2026-08-21T16:31:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086288-associate-director-governance-portfolio-lead 2026-08-21T16:31:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086135-associate-director-strategy-associate 2026-08-21T16:31:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086136-associate-director-strategy-associate 2026-08-21T16:31:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086138-associate-director-strategy-associate 2026-08-21T16:31:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086342-dir-innovative-customer-data-product-lead 2026-08-21T18:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086343-dir-innovative-patient-data-product-lead 2026-08-21T18:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086344-dir-innovative-enterprise-data-product-lead 2026-08-21T18:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086346-dir-spasoc-data-partnerships-lead-specialty-pharmacy-alternative-sites-care 2026-08-21T19:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086333-associate-director-agentic-ai-poc-lead-2-openings 2026-08-21T19:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086326-director-agentic-lab 2026-08-21T19:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086355-ad-data-partnerships-spasoc-specialty-pharmacyalternative-site-care-2-roles 2026-08-21T19:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086116-director-ai-foundations-engineering-2-openings 2026-08-21T19:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086146-director-data-management-office 2026-09-04T16:31:32+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075899-bioprocess-engineer-i-ii 2026-09-08T10:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086353-ad-techops-data-partnerships 2026-08-21T19:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086347-dir-ceimo-data-partnerships-lead-customer-engagementintegrated-marketing-organization 2026-08-27T14:31:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086345-dir-maps-market-access-patient-servicesmedical-data-partnerships-lead 2026-08-27T14:31:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086124-director-core-data-management 2026-08-21T20:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086271-principal-scientist-iii-hematopoietic-stem-cell-rbc-biology 2026-08-25T18:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086352-associate-director-data-partnerships-oncology 2026-08-21T21:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085605-account-manager-ru-ru 2026-08-21T21:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085633-account-manager-ru-ru 2026-08-21T21:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086172-executive-director-head-agentic-factory-remote 2026-08-21T22:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086181-executive-director-novaos-product-lead 2026-08-21T22:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086328-director-novaos-product-owner-1-4 2026-08-21T22:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086322-executive-director-agentic-lab-and-architecture-lead-remote 2026-08-21T22:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085024-manager-senior-manager-public-affairs 2026-08-24T03:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086323-executive-director-semantic-and-knowledge-engineering 2026-08-24T07:31:47+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086338-associate-director-semantic-knowledge-engineering-2-openings 2026-08-24T07:31:47+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086327-director-semantic-knowledge-engineering 2026-08-24T07:31:47+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082666-global-gmp-quality-auditor-pt-br 2026-08-24T17:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086404-senior-manager-marketing 2026-09-03T09:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075171-senior-global-process-owner-risk-based-quality-management 2026-08-24T10:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084379-ai-scientist-ai-driven-target-identification 2026-08-24T12:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085969-ekspert-za-oskrbo-zdravil-mzd-expert-drug-supply-mfd 2026-08-24T13:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085970-strokovni-sodelavec-za-oskrbo-zdravil-mzd-associate-expert-drug-supply-mfd 2026-08-24T14:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085556-preclinical-safety-profiling-lab-associate-senior-scientist-dual-level-posting 2026-08-24T17:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086366-global-gmp-quality-auditor 2026-08-24T18:31:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086325-ed-novaos-strategy-and-innovation-ai 2026-08-24T20:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086603-executive-director-analytics-engineering 2026-08-25T05:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086218-head-execution-excellence 2026-08-25T06:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085812-itot-engineer 2026-08-25T10:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086401-area-manager-regional-business-manager-dermatology-specialty-sales 2026-09-01T07:30:58+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086415-analytical-project-lead-biosimilar-cdmo-mfd 2026-08-25T10:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086626-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-09-04T09:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085852-director-ai-systems-foundations-reusable-capabilities 2026-08-25T11:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084383-ai-scientist-ai-driven-target-identification 2026-08-25T11:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085850-director-ai-systems-reliability-testing-performance 2026-08-25T11:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085270-specialist-quality-control-i 2026-08-25T14:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085408-ops-manager-project-delivery-mfg 2026-09-08T10:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085014-international-trade-analyst-mfd-analitik-mednarodne-trgovine-mzd 2026-08-25T18:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085348-facility-project-engineer 2026-08-25T21:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086451-renal-rare-regional-director-east 2026-08-26T04:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085201-financial-reporting-accounting-specialist-fra-record-reportjinglisuheshiyarisuto 2026-08-26T06:31:53+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086238-clinical-development-medical-manager 2026-09-13T05:32:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086623-manager-global-clinical-supply-group-ja-jp 2026-08-26T08:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086726-sales-representative-territory-business-executive-dermatology-specialty-sales 2026-09-08T08:32:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086728-sales-rep-territory-business-executive-dermatology-specialty-sales 2026-09-01T06:31:53+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086730-sales-rep-territory-business-executive-dermatology-specialty-sales 2026-09-01T07:30:58+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086740-sales-rep-territory-business-executive-dermatology-specialty-sales 2026-09-01T07:30:58+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086729-sales-rep-territory-business-executive-dermatology-specialty-sales 2026-09-01T06:31:53+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086732-sales-rep-territory-business-executive-dermatology-specialty-sales 2026-09-01T07:30:58+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086738-sales-rep-territory-business-executive-dermatology-specialty-sales 2026-09-01T07:30:58+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086735-sales-rep-territory-business-executive-dermatology-specialty-sales 2026-09-01T07:30:58+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086744-area-manager-regional-business-manager-dermatology-specialty-sales 2026-09-01T07:30:58+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086731-sales-rep-territory-business-executive-dermatology-specialty-sales 2026-09-01T07:30:58+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086733-sales-rep-territory-business-executive-dermatology-specialty-sales 2026-09-01T07:30:58+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086737-sales-representative-senior-territory-account-specialist-dermatology-specialty-sales 2026-09-01T07:30:58+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086739-sales-rep-territory-business-executive-dermatology-specialty-sales 2026-09-01T07:30:58+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086743-area-manager-regional-business-manager-dermatology-specialty-sales 2026-09-01T07:30:58+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086741-area-manager-regional-business-manager-dermatology-specialty-sales 2026-09-01T07:30:58+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082014-ot-quality-associate 2026-08-26T09:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086581-brand-manager-retail-marketing-patient-insights-engagement 2026-08-26T11:31:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076588-qc-analyst-ii-mwd-microbioanalytics-2-2-tagschichtmodell-moglich 2026-08-26T13:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086616-discovery-postdoctoral-fellow-camp-biology 2026-08-26T15:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086664-international-trade-analyst 2026-08-26T16:31:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086665-international-trade-analyst 2026-08-26T16:31:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086426-director-portfolio-analytics 2026-08-26T16:31:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086799-director-portfolio-analytics 2026-08-26T19:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086525-director-data-science-3-openings 2026-08-26T23:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086436-site-quality-head 2026-09-13T05:32:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074792-senior-expert-ii-tppm 2026-09-13T05:32:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081512-analyst-provider-mdm 2026-08-27T07:31:39+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081513-senior-analyst-provider-mdm 2026-08-27T07:31:39+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086236-senior-analyst-brand-analytics 2026-08-27T08:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084241-technical-transfer-lead-fmd-manufacturing-sciences-technology-temporary 2026-08-27T08:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086669-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-09-04T10:32:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086719-access-field-manager 2026-08-27T10:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086121-recruitment-experience-partner 2026-08-27T10:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086118-recruitment-experience-partner-usa 2026-08-27T10:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086717-access-field-manager 2026-08-27T10:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086562-manager-field-operations 2026-08-27T11:31:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085415-research-scientist-immunology 2026-08-27T11:31:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086416-equipment-operator-i-3-mfd-de-de 2026-08-27T12:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086578-senior-principal-data-scientist 2026-08-27T13:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086779-senior-principal-data-scientist 2026-08-27T13:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086460-pks-integration-operations-manager 2026-08-27T17:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086707-portfolio-account-specialist-oncology 2026-09-09T00:31:41+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086834-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-09-04T10:32:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086962-gaojidaqujingli 2026-09-04T09:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086033-supply-chain-head 2026-08-28T08:31:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080920-junior-customer-service-analyst-posicao-afirmativa-para-pessoas-com-deficiencia-pt-br 2026-08-28T09:31:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086375-sales-representative-immunology-taipei 2026-09-02T17:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085573-sales-representative-immunology 2026-09-02T03:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080457-global-regulatory-associate-director-life-cycle-management 2026-08-28T10:31:54+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085156-research-scientist-i-or-ii-oligonucleotide-chemistry 2026-08-28T12:31:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085163-principal-scientist-iii-oligonucleotide-chemistry-innovation 2026-08-28T12:31:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082193-ast-expert 2026-08-28T13:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076684-director-therapeutic-area-strategy-crm 2026-08-28T15:34:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085042-ast-specialist 2026-09-08T10:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085045-quality-control-specialist-ii 2026-09-08T10:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076215-director-therapeutic-area-strategy-crm 2026-08-28T15:34:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081681-site-hse-specialist 2026-09-08T10:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086920-rheumatology-territory-account-specialist-santa-barbara-san-luis-obispo 2026-08-28T20:33:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086450-associate-director-performance-reporting 2026-08-28T21:31:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086929-cardiovascular-territory-account-specialist-hartford-ct 2026-08-28T23:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087008-cardiovascular-territory-account-specialist-dallas-tx-south 2026-08-28T23:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085682-analytical-expert-science-technology 2026-08-30T22:31:51+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082442-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-09-04T09:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085411-senior-brand-manager-bc 2026-09-04T06:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086872-executive-assistant 2026-09-13T05:32:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086037-hse-head-commercial-operations-malaysia-indonesia-singapore-thailand 2026-09-08T14:33:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080751-operater-v-proizvodnji-trdnih-izdelkov-mzd 2026-08-31T05:30:58+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085104-lifecycle-management-manager 2026-08-31T06:31:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084119-maintenance-coordinator-instrumentation-mwd 2026-08-31T08:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086383-customer-success-content-enablement-platforms 2026-08-31T09:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086878-medical-affairs-head-serbia-montenegro 2026-08-31T09:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086921-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-09-04T10:32:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082365-asset-life-cycle-lead 2026-08-31T10:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086594-associate-qa-operations-expert-release 2026-08-31T10:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085268-qc-analist-ii-microbiologie 2026-08-31T10:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086025-expert-science-and-technology-gene-therapy-analytical-development-chemistry 2026-09-04T07:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086487-skrbnik-oskrbe-kupcev-mzd 2026-08-31T11:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083694-senior-quality-control-specialist 2026-08-31T12:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087043-manager-us-bpa 2026-08-31T12:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085629-process-expert-mfd-de-de 2026-08-31T13:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086099-senior-asset-management-specialist-fixed-assets-and-lease-accounting 2026-08-31T14:31:51+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086024-recruitment-experience-partner-1-year-contract 2026-08-31T14:31:51+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086777-expert-science-technology 2026-08-31T14:31:51+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085941-specialist-quality-operations 2026-08-31T14:31:51+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086691-dermatology-territory-account-specialist-edison-nj 2026-09-02T18:31:45+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086694-dermatology-territory-account-specialist-st-louis-mo 2026-09-09T17:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086890-director-hematology-cls 2026-08-31T16:31:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086998-therapeutic-area-biomarker-director-cardiovascular-and-metabolism 2026-08-31T17:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084970-digital-marketing-execution-manager 2026-08-31T18:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084817-sales-rep-institutional-territory-business-executive 2026-09-01T03:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074120-therapy-area-medical-head 2026-09-01T03:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080301-operater-v-pakirnici-mzd 2026-09-01T04:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081980-associate-director-customer-engagement-communications 2026-09-01T04:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077915-mehanik-v-enoti-pakiranje-mzd 2026-09-01T04:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085329-brand-manager 2026-09-01T07:30:58+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087033-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-09-04T10:32:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083024-senior-expert-engineering-device-development-fmd 2026-09-01T09:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085492-usp-research-scientist-ii 2026-09-01T09:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086960-gaojidaqujingli 2026-09-08T10:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084626-access-field-head 2026-09-01T10:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086887-logistics-operations-manager 2026-09-01T11:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082892-global-financial-controls-compliance-process-experts-senior-manager 2026-09-01T11:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075484-expert-science-technology-analytical-development-potency-and-flow 2026-09-01T11:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077834-technical-steward-i-mfd-ekspert-procesnih-tehnologij-i-mzd 2026-09-01T12:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083741-global-head-clinical-assurance-quality-development-unit 2026-09-01T12:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086909-therapeutic-area-biomarker-director-cardiovascular-and-metabolism 2026-09-01T13:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082017-field-access-manager 2026-09-01T13:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086801-ad-data-partnerships-rare-disease 2026-09-01T14:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086883-quality-assurance-operations-lead 2026-09-01T15:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078138-clinical-program-lead-cpl-rlt-focus 2026-09-01T16:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086380-customer-success-manager-content-enablement-platforms 2026-09-01T17:31:56+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080652-cardiovascular-territory-account-specialist-orlando-fl-south 2026-09-04T22:33:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086654-principal-statistical-programmer 2026-09-01T18:31:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086844-senior-expert-science-technology 2026-09-04T04:31:24+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087039-ast-specialist-mzd 2026-09-02T06:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087152-medical-manager 2026-09-02T08:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085869-scientific-engagement-program-manager 2026-09-02T09:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078502-specialiste-comptabilite-generale-senior-hf 2026-09-02T09:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083048-sr-operations-manager 2026-09-02T09:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086576-sales-representative-rlt 2026-09-02T10:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086405-brand-manager 2026-09-02T10:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084443-assoc-director-statistical-programming 2026-09-02T12:31:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081727-senior-principal-developer 2026-09-02T12:31:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081379-senior-principal-developer 2026-09-02T12:31:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087036-director-ddit-ies-chs-aws-engineering 2026-09-02T13:31:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086854-director-ai-systems-reliability-testing-performance 2026-09-02T13:31:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084487-translational-medicine-directorassociate-cardiovascular-metabolic 2026-09-02T13:31:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086761-quality-control-officer 2026-09-02T13:31:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086855-director-ai-systems-foundations-reusable-capabilities 2026-09-02T13:31:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087144-neuroscience-territory-account-specialist-cherry-hill 2026-09-02T13:31:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086795-senior-expert-data-science 2026-09-02T14:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086677-supply-chain-management-expert 2026-09-02T15:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087256-medical-science-liaison-neuroscience 2026-09-02T15:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085652-associate-director-data-engineering-web-analytics 2026-09-02T16:31:32+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086604-associate-director-nonclinical-safety-assessment-expert-0ncology 2026-09-02T17:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087164-sales-representative-immunology-chiayiyunlin 2026-09-02T17:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086364-associate-director-data-modelling-lead 2026-09-02T19:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086361-associate-director-data-quality-lead 2026-09-02T19:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087099-join-novartis-talent-community-2026 2026-09-02T19:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086865-associate-directordirector-portfolio-strategy-and-operations-cardio-renal-metabolic-development-unit-80-100 2026-09-02T19:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086362-associate-director-metadata-and-semantics-lead 2026-09-02T19:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079280-integrated-insights-manager 2026-09-02T20:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084385-congress-project-manager 2026-09-11T19:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086690-dermatology-territory-account-specialist-austin-south-tx 2026-09-02T20:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075493-cardiovascular-territory-account-specialist-stockton-ca 2026-09-02T23:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087070-associate-director-launch-operations 2026-09-04T15:31:51+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075912-radioligand-therapies-rlt-sales-specialist-prostate-new-mexicowest-texas 2026-09-02T23:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086676-pros-rare-disease-business-leader-canv 2026-09-03T01:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086571-project-director 2026-09-13T05:32:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085731-associate-director-hcp-marketing-strategy-neuromuscular-disease 2026-09-03T04:30:58+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085267-country-japan-h2r-services-manager 2026-09-03T05:31:23+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086984-equipment-operator-i-de-de 2026-09-03T06:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087125-manager-market-engagement-governance 2026-09-03T07:32:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087127-associate-director-governance-operations 2026-09-03T07:32:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087142-senior-manager 2026-09-03T08:31:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087155-translational-medicine-directorassociate-cardiovascular-metabolic 2026-09-03T13:31:32+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077370-brand-manager 2026-09-11T15:31:42+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087151-associate-director-crm-innovation-labs 2026-09-03T13:31:32+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087006-msl 2026-09-03T14:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087149-senior-manager-crm-innovation-experimentation 2026-09-03T14:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086039-senior-brand-manager-immunology 2026-09-03T14:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086936-senior-revenue-specialist 2026-09-03T14:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086957-warehouse-process-expert 2026-09-03T15:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086561-sales-rep-territory-business-executive 2026-09-03T15:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086805-director-international-value-access-oncology 2026-09-03T15:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086930-canada-payroll-lead 2026-09-03T17:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086932-canada-payroll-analyst-temporary-role-6-months 2026-09-03T17:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087146-cardiovascular-territory-account-specialist-butler-pa 2026-09-03T17:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086969-regulatory-affairs-specialist-1-year-fixed-term-contract 2026-09-07T05:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086819-director-inclusive-access-strategy-market-integration 2026-09-03T18:31:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086824-director-sis-community-impact-patient-reach 2026-09-03T18:31:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087078-scientific-computing-engineer-drug-product-process-modeling-data-science 2026-09-08T13:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087286-representante-de-ventas-inmunologia-es-es 2026-09-03T22:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087301-medical-representative-cardiovascular-metabolism-ha-noi 2026-09-04T04:31:24+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087296-mr-intern-zh-cn 2026-09-04T04:31:24+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087338-mr-intern-zh-cn 2026-09-04T04:31:24+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086107-clinical-project-manager-es-es 2026-09-04T07:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087102-senior-administrative-assistant-ii 2026-09-09T14:32:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078081-tcm-i-business-analyst 2026-09-04T09:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081830-global-good-clinical-practices-pharmacovigilance-auditor 2026-09-04T10:32:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084618-gaojidaqujingli-zh-cn 2026-09-04T11:32:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086943-executive-assistant-hr-leadership 2026-09-04T12:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087072-hire-retire-services-expert-german-speaker 2026-09-04T12:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086515-executive-director-international-value-access-immunology 2026-09-04T13:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086551-study-grants-manager 2026-09-04T14:33:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084566-study-grants-manager 2026-09-04T14:33:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086249-project-manager-robotics-automation-mfd 2026-09-04T14:33:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086552-study-grants-manager 2026-09-04T14:33:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086250-project-manager-mfd 2026-09-04T14:33:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086915-shipping-and-receiving-specialist 2026-09-04T16:31:32+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086948-ad-data-governance-lead 2026-09-04T16:31:32+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084656-head-adoption-and-value-realization 2026-09-04T16:31:32+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086851-specialist-platform-engineer-python-developer 2026-09-04T16:31:32+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086949-ad-data-governance-solutions-lead-3-openings 2026-09-04T16:31:32+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087184-radioligand-therapies-rlt-associate-director-priority-accounts-kentuckytennesseesouth-carolina 2026-09-04T21:32:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085392-process-engineer-i 2026-09-08T10:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087187-project-manager-pmo-marketing-es-es 2026-09-05T00:32:39+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087447-senior-ta-rep-hema 2026-09-06T11:31:54+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087168-director-future-field-engagement-strategy-metrics-incentives 2026-09-06T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087094-oncology-territory-account-specialist-solid-tumor-macon-ga 2026-09-06T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087209-clinical-research-associate 2026-09-06T18:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087027-account-manager-oncology 2026-09-07T01:31:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081809-portfolio-management-lcm-associate-lead-senior-lead 2026-09-07T03:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081984-mehanik-v-proizvodnji-trdnih-izdelkov-mzd 2026-09-07T04:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087390-ddit-ops-sm-automation-engineer-changping 2026-09-13T05:32:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086634-project-engineer-utility 2026-09-13T05:32:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086627-senior-project-engineer 2026-09-13T05:32:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087448-gaojishangwujingli-zh-cn 2026-09-13T05:32:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087318-new-products-lead 2026-09-07T07:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086964-specialist-upravljanja-kakovosti-skladnost-mzd 2026-09-07T07:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087456-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-09-07T07:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086659-computerized-systems-expert-mfd 2026-09-07T09:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086906-senior-analyst 2026-09-07T09:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085426-maintenance-coordinator-mechatronics 2026-09-07T09:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086942-travel-and-expense-specialist-es-es 2026-09-07T09:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086994-specialist-upravljanja-kakovosti-ii-operacije-mzd 2026-09-07T10:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086646-commercial-portfolio-manager 2026-09-07T10:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087153-senior-product-analyst 2026-09-07T11:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086908-shift-lead-i-mwd 2026-09-07T11:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087281-senior-manager-bpa-finance 2026-09-07T13:31:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087042-specialist-upravljanja-kakovosti-ii-operacije-mzd 2026-09-07T13:31:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087486-senior-manager-analytical-science-technology-technical-development 2026-09-07T13:31:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086880-strokovni-sodelavec-za-oskrbo-zdravil-mzd-associate-expert-drug-supply-mfd 2026-09-07T14:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086688-translational-medicine-expert-gastroenterology-associate-director 2026-09-07T14:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085043-data-management-infrastructure-manager 2026-09-07T14:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087000-translational-medicine-expert-gastroenterology-associate-director 2026-09-07T14:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087052-biomarker-therapeutic-area-head-neuroscience 2026-09-07T15:31:49+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087212-ta-medical-lead-immunology 2026-09-07T16:33:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081684-sales-representative-immunology-monterrey 2026-09-07T17:32:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084872-associate-director-marketing-capability-delivery 2026-09-07T19:31:41+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084875-manager-marketing-capability-delivery 2026-09-07T19:31:41+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087315-data-management-infrastructure-manager 2026-09-07T22:31:51+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10079302-russia-country-ethics-risk-compliance-head 2026-09-07T22:31:51+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087231-technical-manager 2026-09-08T02:32:21+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087252-qa-manager-eso-srt-china 2026-09-08T02:32:21+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087234-technical-manager 2026-09-08T02:32:21+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087465-gaojidequjingli-renal-zh-cn 2026-09-13T05:32:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087479-gaojidequjingli-zh-cn 2026-09-08T03:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087461-gaojidequjingli-renal-zh-cn 2026-09-13T05:32:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087498-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-09-08T03:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087462-gaojidequjingli-renal-zh-cn 2026-09-13T05:32:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087459-gaojidequjingli-zh-cn 2026-09-08T03:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084551-senior-marketing-manager-hema 2026-09-13T05:32:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087477-gaojidequjingli-zh-cn 2026-09-08T06:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087471-gaojidequjingli-zh-cn 2026-09-08T06:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087476-gaojidequjingli-zh-cn 2026-09-08T06:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086974-qc-analyst-de-de 2026-09-08T10:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087473-gaojidequjingli-zh-cn 2026-09-08T07:31:43+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087400-global-clinical-operations-senior-cra-zh-cn 2026-09-08T07:31:43+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086973-qc-analyst-1-de-de 2026-09-08T10:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087455-sr-spec-ddit-ops-itot-sm-site-robotics 2026-09-13T05:32:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087463-district-manager-zh-cn 2026-09-08T08:32:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083088-business-planning-analysis-manager 2026-09-08T19:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086863-regulatory-affairs-head-israel 2026-09-08T09:32:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087436-sales-rep-territory-business-executive 2026-09-08T10:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078476-ai-engineer 2026-09-08T10:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087439-sales-rep-territory-business-executive 2026-09-08T10:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086901-specialist-upravljanja-kakovosti-i-skladnost-mzd 2026-09-08T10:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087030-invoice-cash-specialist-spanish 2026-09-08T10:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081199-medical-scientific-liaison-mwd-hema 2026-09-08T10:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078477-data-engineer 2026-09-08T11:32:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083886-validation-lead 2026-09-08T11:32:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087243-senior-manager-ce-compliance-field-inquiries 2026-09-08T12:34:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087225-ta-lead-neuroscience 2026-09-08T12:34:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087045-senior-robotics-specialist 2026-09-10T06:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087208-director-operations-so 2026-09-08T12:34:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087123-associate-director-business-process-excellence 2026-09-08T13:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087277-country-quality-manager 2026-09-08T13:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085696-ad-data-science 2026-09-08T14:33:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086446-senior-clinical-research-associate-midwest 2026-09-08T16:32:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087417-dermatology-territory-account-specialist-baltimore-bethesda 2026-09-08T16:32:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087131-itot-robotics-expert 2026-09-08T17:33:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086856-senior-specialist-platform-analytics-ai-python-and-aws 2026-09-08T17:33:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087521-business-process-excellence-lead 2026-09-08T17:33:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087555-clinical-scientific-expert-1 2026-09-08T17:33:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087557-clinical-scientific-expert-1 2026-09-08T17:33:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087560-clinical-scientific-expert-i 2026-09-08T17:33:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087559-clinical-scientific-expert-i 2026-09-08T18:31:19+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073887-associate-director-eprm 2026-09-08T18:31:19+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085720-global-clinical-operations-ai-program-associate-director 2026-09-08T19:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085717-global-clinical-operations-ai-product-director 2026-09-08T19:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087083-director-peer-peer-marketing-strategy-radioligand-therapy 2026-09-08T19:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084563-director-rd-legal-americas 2026-09-08T19:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076829-agile-delivery-lead-scrum-kanban 2026-09-09T10:33:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10050665-assoc-dir-ddit-ies-hpc-infrastructure-sr-engineer 2026-09-08T19:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086832-business-planning-analysis-manager 2026-09-08T21:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087260-dermatology-regional-director-east 2026-09-08T21:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087174-dermatology-territory-account-specialist-des-moines-ia 2026-09-08T21:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084083-global-clinical-operations-ai-product-director 2026-09-08T22:31:51+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084128-global-clinical-operations-ai-program-associate-director 2026-09-08T22:31:51+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085718-global-clinical-operations-ai-program-associate-director 2026-09-08T23:33:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085714-global-clinical-operations-ai-product-director 2026-09-08T23:33:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085719-global-clinical-operations-ai-program-associate-director 2026-09-08T23:33:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085715-global-clinical-operations-ai-product-director 2026-09-08T23:33:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086899-director-marketing-strategy-radical-early-action 2026-09-09T00:31:41+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086829-associate-director-marketing-strategy-immunology 2026-09-09T02:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10081909-japan-program-manager-ja-jp 2026-09-09T02:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084106-global-clinical-operations-ai-product-director 2026-09-09T04:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084129-global-clinical-operations-ai-program-associate-director 2026-09-09T04:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087192-toxicology-study-monitor-principal-scientist-iii 2026-09-09T04:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084604-seniorbrand-manager 2026-09-09T05:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087482-gaojidequjingli-zh-cn 2026-09-09T05:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087478-gaojidequjingli-zh-cn 2026-09-09T05:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087470-gaojidequjingli-zh-cn 2026-09-09T05:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087472-district-manager-zh-cn 2026-09-09T05:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087468-gaojidequjingli-renal-zh-cn 2026-09-13T05:32:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086029-senior-brand-manager 2026-09-09T09:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080459-tehnolog-proizvodnega-inzeniringa-lokacije-mzd 2026-09-09T09:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087619-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-09-13T05:32:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080293-project-management-lead 2026-09-09T10:33:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087120-maintenance-coordinator-instrumentation 2026-09-09T10:33:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086015-qa-operations-expert 2026-09-09T10:33:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085115-equipment-operator-de-de 2026-09-09T14:32:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086086-junior-process-expert 2026-09-09T14:32:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087068-quality-control-lead-chemistry 2026-09-09T14:32:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086619-neuroscience-territory-account-specialist-austin-san-antonio 2026-09-09T15:32:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085516-time-service-delivery-specialist-fixed-term-12-months 2026-09-09T15:32:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086418-director-therapeutic-area-strategy-neuroscience 2026-09-09T15:32:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087186-sr-automation-engineer-downstreambuffer 2026-09-09T16:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077151-clinical-program-leader-cpl 2026-09-09T16:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083887-senior-python-developer 2026-09-09T16:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086628-itot-senior-lab-specialist 2026-09-09T16:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087185-sr-automation-engineer-upstreammedia 2026-09-09T16:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087180-automation-engineer-iii-compoundingcipsiputility-distribution 2026-09-09T16:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087183-senior-engineer-automation-packagingserialization 2026-09-09T16:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087181-automation-engineer-iii-bmsplcoem 2026-09-09T16:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087425-junior-payments-specialist-us-es-es 2026-09-09T16:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086624-sr-manager-automation-gtx-lead 2026-09-09T17:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087087-americas-region-head-global-security 2026-09-09T17:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082356-gcp-compliance-director-program-study 2026-09-09T17:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086853-rd-legal-counsel-emea 2026-09-09T17:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083379-gcp-compliance-director-emea-hub 2026-09-09T17:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087271-site-robotics-lead 2026-09-09T17:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085820-discovery-postdoctoral-fellow-target-biology-oncology 2026-09-09T17:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087213-associate-director-assessment-selection 2026-09-09T17:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085086-record-report-team-lead-product-cost-and-accounting-rlt-ldc-inventory-accounting-reporting-temporary 2026-09-09T18:31:53+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087606-director-therapeutic-area-strategy-neuroscience 2026-09-09T18:31:53+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087608-head-state-policy 2026-09-09T22:33:32+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087444-allergy-territory-account-specialist-detroit-and-ann-arbor-mi-overlay 2026-09-09T23:32:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085077-clinical-research-associate-it-it 2026-09-10T02:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084575-sales-rep-senior-territory-business-executive-crm 2026-09-11T07:33:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087586-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-09-10T03:31:23+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087575-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-09-10T03:31:23+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087657-gaojiquyushichangjingli-pc-zh-cn 2026-09-13T05:32:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085495-senior-manager-br-global-initiative 2026-09-10T05:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087215-laboratorijski-analitik-iii-mzd 2026-09-10T07:31:43+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075602-manager 2026-09-10T06:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087586-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-09-10T03:31:23+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087575-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-09-10T03:31:23+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087657-gaojiquyushichangjingli-pc-zh-cn 2026-09-12T05:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085495-senior-manager-br-global-initiative 2026-09-10T05:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087215-laboratorijski-analitik-iii-mzd 2026-09-10T07:31:43+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075602-manager 2026-09-10T06:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087671-mehanik-mzd-sl-si 2026-09-10T06:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087579-tehnik-ii-mzd-sl-si 2026-09-10T06:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086987-head-legal-germany-mfd 2026-09-10T07:31:43+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076461-associate-director-crm-ta-access 2026-09-10T07:31:43+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082965-procesni-specialist-v-logistiki-enote-pakiranja-mzd 2026-09-10T08:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087291-development-quality-assurance-managerexpert-ja-jp 2026-09-10T08:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087708-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-09-10T08:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077830-ekspert-upravljanja-kakovosti-skladnost-mzd 2026-09-10T09:33:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086428-vodja-odlicnosti-terena-mzd-field-excellence-manager-mfd 2026-09-10T09:33:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087503-specialist-kontrole-kakovosti-iii-mzd 2026-09-11T12:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087596-field-incentives-and-ops-excellence-manager 2026-09-10T10:33:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087624-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-09-10T10:33:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085470-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-09-10T10:33:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087597-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-09-10T10:33:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087594-maintenance-shift-supervisor-nights 2026-09-10T13:31:41+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085863-vodja-kakovosti-eso-koncni-izdelki-mzd-quality-eso-fdf-head-mfd 2026-09-10T13:31:41+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078998-technical-product-owner-data-science-ai-platforms 2026-09-10T14:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086553-study-grants-manager 2026-09-10T14:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080354-rlt-engineering-lead 2026-09-10T14:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087520-regulatory-affairs-head-egypt 2026-09-10T14:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076170-senior-director-us-risk-management-product-safety-rems 2026-09-10T15:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087632-sales-representative-immunology-abu-dhabi 2026-09-11T07:33:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082525-associate-director-it-solution-delivery-cookies-and-digital-tracker 2026-09-10T16:32:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087084-ultra-rare-disease-territory-account-specialist-austinhouston-tx 2026-09-10T17:32:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083616-operational-controls-manager 2026-09-10T19:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086916-senior-expert-engineering 2026-09-10T22:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087330-senior-manager-process-analytical-sciences-mfd-vodjo-skupine-procesne-analitike-mzd 2026-09-10T23:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085993-supply-operations-specialist 2026-09-11T03:35:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087737-laboratorijski-analitik-ii-qc-analyst-ii 2026-09-11T05:32:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10083344-sales-rep-institutional-territory-business-executive-crm 2026-09-11T07:33:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084510-sales-rep-institutional-territory-business-executive-senior-territory-business-executive-area-sales-manager-crm 2026-09-11T07:33:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084950-territory-business-executive-tbe-crm 2026-09-11T07:33:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087580-clinical-development-head-neuroscience 2026-09-11T08:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087709-associate-commercial-portfolio-manager 2026-09-11T08:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084951-territory-business-executive-tbe-crm 2026-09-11T08:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077336-senior-analyst-forecasting 2026-09-11T08:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087738-gaojiyiyaodaibiaozishenchanpinzhuanyuan-zh-cn 2026-09-11T08:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087712-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-09-11T08:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084187-sr-specialist-ddit-ies-database-services 2026-09-11T09:34:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085058-clinical-research-medical-advisor-crma 2026-09-11T09:34:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087809-process-team-lead 2026-09-11T09:34:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087715-senior-brand-manager-renal 2026-09-12T05:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086683-shift-lead-ii-automation-assembly-packaging-mfd-de-de 2026-09-11T10:31:42+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085501-senior-financial-analyst 2026-09-11T10:31:42+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078167-commercial-partnerships-lead-apma 2026-09-11T10:31:42+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078733-tehnolog-proizvodnega-inzeniringa-lokacije-i-mzd 2026-09-11T10:31:42+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087170-associate-director-treasury 2026-09-11T11:31:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087648-tehnik-v-enoti-pakiranja-mzd 2026-09-11T11:31:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077699-msl-neurosciences 2026-09-11T12:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085203-value-access-ta-head-oncology-apma 2026-09-11T12:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085205-value-access-ta-head-immunology-neuroscience-apma 2026-09-11T12:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085216-value-access-ta-head-crm-apma 2026-09-11T12:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087335-early-career-associate 2026-09-11T13:32:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087796-quality-project-lead-ftc 2026-09-11T14:31:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10080426-clinical-scientific-expert-cse-i 2026-09-11T14:31:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086110-director-business-excellence-lead-cml 2026-09-11T14:31:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087532-equipment-specialist 2026-09-11T15:31:42+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086917-ai-innovation-postdoctoral-fellow-digital-pathology 2026-09-11T15:31:42+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087739-msl-renal-es-es 2026-09-11T15:31:42+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087530-equipment-operator 2026-09-11T16:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085169-gcp-compliance-director-program-study 2026-09-11T17:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087705-therapeutic-area-head-oncology 2026-09-11T17:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087385-representante-de-ventas-oncologia-es-es 2026-09-11T17:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10085976-regional-supply-chain-intern 2026-09-11T18:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084384-sales-representative-neurology-es-es 2026-09-11T18:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087177-manager-ethics-risk-and-compliance 2026-09-11T19:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086643-asset-rights-and-source-manager 2026-09-11T19:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087605-ed-hcp-marketing-strategy-radioligand-therapy 2026-09-11T20:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10087609-vphead-medical-affairs-cluster-head-neuroscienceimmunology-us-medical-affairs 2026-09-11T20:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084799-statutory-and-technical-accounting-manager-es-es 2026-09-11T20:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10086537-associate-director-analytical-operations 2026-09-11T22:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10084584-oncology-territory-account-specialist-solid-tumor-edison-nj 2026-09-11T23:32:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10082796-senior-legal-manager-government-affairs-public-procurement 2026-09-12T00:31:09+00:00 daily 0.5